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Abstract 
 
Synthesis of Isoxazoline-N-oxide through [3+2] Cycloaddition 
Wenyan Liao 
 
A catalytic cascade synthesis of Isoxazoline N-oxide was developed through proline-
catalyzed nitroalkene activation. A large variety of nitroalkenes and vinyl esters were 
suitable for this transformation, giving only trans isomer with good to excellent yields. 
Mechanistic studies revealed intramolecular  cycloaddition as the rate-determining step. 
This strategy provided not only a new approach for the construction of substituted 
isoxazoline derivatives but  further evidence of secondary amine nucleophilic activation 
of nitroalkene, an alternative path of proline catalysis. 
 
 
 
 
Development of 1,2,3-Triazole-Borane Complex as Effective Reagent for 
Aldehyde/Ketone Reductive Amination 
Wenyan Liao 
 
Air, moisture and thermally stable 1,2,3-triazole-boranes were successfully prepared and 
applied as reductants in aldehyde/ketone reductive amination with high efficiency and 
excellent substrate diversity. Detailed studies regarding to the reaction mechanism and 
application of this new reagent for other important transformations are currently under 
investigation in our group. 
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 1
Part I 
Synthesis of Isoxazoline N-oxide through [3+2] 
Cycloaddition 
1. Introduction 
1.1 Cascade reaction in organic synthesis 
In modern organic synthesis, efficiency in constructing complex frameworks became 
more and more important in both academic and industrial research. As one of the most 
popular techniques to date, multi-component organo catalytic cascade reaction has been 
widely used to synthesize the backbones of natural compounds due to its high atomic 
economy and possibility to obtain good stereo selectivity. 
 
1.2 Lewis base catalysis 
    In year 2000, the term “organocatalysis” was brought forward by David Macmillan. 
Since then, the area became more and more important as an useful methodology. Two 
main advantages of organocatalysis are:1 There is no need for metal-based catalysis thus 
making a contribution to green chemistry. 2 When the organocatalyst is chiral, an avenue 
is opened to asymmetric catalysis. Common organocatalysts are based on nitrogen such 
as pyridine used in the Doebner modification of the Aldol condensation, DMAP used in 
esterifications, DABCO used in the Baylis-Hillman reaction. In the 1970s, a pioneering 
asymmetric organocatalysed reaction  was developed by Hoffmann-La Roche1,2, Schering 
AG3 and Hajos-Parrish. Among the most reported small organic catalysts, proline 
analogues are popular due to good accessibility and high efficiency. In the reaction, 
carbonyl group was activated by proline to form corresponding enamin or iminum cation 
(Scheme 1). Many reactions can be carried out by this strategy, such as Aldol reaction, 
Mannich reaction, Michael addition, Friedel-Crafts alkylation, epoxidation and Diel-
Alder reaction. 
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    Meanwhile, with the presence of nitrogen lone-pair electrons, amines can also serve as 
Lewis base catalyst. Lewis base catalysis is the process which an electron-pair donor 
increases the rate of a given chemical reaction by interacting with an acceptor atom in 
one of the substrates or the reagents. The binding event may enhance either the 
electrophilic or nucleophilic character of the bound species so that the reaction can 
happen (Scheme 2)4. Further more, the Lewis base should not be consumed or altered 
during the course of the reaction. Although Lewis base activation is quite common, it is 
less widely employed compared to Lewis acids in organic synthesis. Reasons for this 
include the lack of target Lewis acidic sites as well as the limited number of opportunities 
for valence expansion at carbon centers. 
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Scheme 2. Parallels between the Catalyzed (right) and Uncatalyzed Reactions (left) of 
                  Unsaturated  Functional Groups
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1.3 Literature reported synthesis of isoxazoline N-oxide and its     
      applications 
 
    Isoxazoline N-oxides and their derivatives are frequently used as intermediates in the 
synthesis of complex molecules in chemical5 and biological field6. In the year 1964, the 
fact that nitronic esters undergo 1,3-dipolar cycloaddition to olefins to afford 
isoxazolidine was discovered and developed by Tartakovskii and co-workers7 (Scheme 3).  
 
(NO2)2C NO2CH3 + RHC=CH2
N
OR OCH3
NO2
NO2
Scheme 3. Synthesis of Isoxazolidine
 
 
    Later on, they developed a strategy by using trinitromethane silver salt react with 
trimethylsilylchloride to form silylnitronate, followed by [3+2] cycloaddition and 
elimination to give isoxazoline N-oxide as product8. One synthesis was done recently by 
using the similar pathway in Tartakovskii’s group9 (Scheme 4). 
 
Scheme 4. Synthesis of Isoxazoline-N-oxide by Tartakovskii
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R
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In 1976, Holy reported that dimethylsulfoxanium methylide could react with 
nitroalkene to afford isozaxoline N-oxides in the presence of copper(I)10 (Scheme 5).  
 
N
O
CH3
O
Ph
S
O
I + NaH + CuI +
NO2H3C
Ph
Scheme 5. Synthesis of Isoxazoline N-oxide by Holy
Ph CH3
N O
O
Me2S
O
 
    After the pioneer work, different alkyl nitronate was developed for O-alkylation to 
synthesis isoxazoline N-oxide. It is known that reactions at C atom of nitro compound 
can happen with different electrophiles, such as aldehydes and epoxides. Thus the 
incorporation of the nitro moiety and the cycloaddiction can be combined into a tandem 
sequence. Examples are shown in Scheme 6. 
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Scheme 6. Synthesis of Isoxazoline N-oxide via O-alkylation
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    Overall, among the developed protocols, two types of strategies are highly appreciated. 
One path is the intramolecular O-alkylation of aliphatic nitro compounds. However, no 
general method for the synthesis of such starting nitro compounds is available, each 
particular substrate requires special approach. The other way is the highly efficient hetero 
cycloaddition between nitronates and alkenes (known as [3+2]). Elimination from cyclic 
nitronic ester to isoxazoline N-oxide remains a challenge for this methodology. 
 
    The stereoselective synthesis of isoxazoline N-oxide is an important task in the context 
of synthetic strategies toward the preparation of biological target molecules such as 
polyhydroxylated amino acids, aminopolyols and amino sugars11. Within one step 
reduction, isoxazoline can obtained from isoxazoline N-oxide. N-O bond cleavage of 
isoxazoline followed by hydrolytic workup provides β-hydroxyketone, hence provides 
and alternate route to an aldol product. The dehydrogenation of intermediate 
iminoalcohol arising from N-O bond cleavage affords β-hydroxy nitriles. Complete 
reduction of the isoxazoline ring delivers γ-aminoalcohols. Base-mediated ring opening 
would provide α, β-unsaturated oximes (Scheme 7). All the hydroxyl compounds can be 
easily dehydrated or the other functional group can be transformed further to obtain 
synthetically useful molecules. 
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Scheme 7. Ring Opening Application
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    The dipolar character of  these cyclic nitronates can be exploited for further 1,3-dipolar 
cyloaddition with olefins to afford multicyclic structure moiety in total synthesis. The 
placement of the tether at the C3 position of the nitronate provides access to the spiro 
mode cycloadditions. This class has been evaluated for the preparation of five- and six-
membered spiro ring systems12 (Scheme 8).  
 
Scheme 8. Spiro Mode Intramolecular Cycloadditions
N
On-BuO O
R1R2
n=4
75oC, 1.5h N
On-BuO O
n=4
R1
R2
 
    Rosini’s group reported the first example of a silicon-tethered intramolecular 1,3-
dipolar cycloaddition13. The tricyclic compound was converted to the corresponding 
bicyclic diol by an oxidative removal of the temporary silicon linker. The unstable diol 
was protected immediately as the diacetate. Reductive ring opening of the nitroso acetal 
moiety was performed with hygrogen and a catalytic amount of Raney Ni, to afford the 
polyhydroxylated aminolactone derivative (Scheme 9). 
 
O N
O
COOEt
OH
Bu
H
+ Si
Cl O N O
Bu
H
EtOOC
O Si
O N O
Bu
H
EtOOC
AcO OAc
OH
OAcOAc
Bu
HO
O OEt
NH2 O
O
Bu
OAc
OH
OAc
NH2
Imidazole 1. KF, KHCO3, H2O2
Me
O
Cl
2. , Et3N, DMAP
Raney Ni, H2
Scheme 9. Transformation of Isoxazoline N-oxide
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2. Research Objective 
2.1 Lewis-base catalyzed cascade cross conjugated addition 
    Recently, our group reported a catalytic cascade intermolecular double Michael 
addition between β-alkyl nitroalkenes and enones14 (Scheme 10). Experimental and 
computational studies suggested that L-proline served as an effective Lewis base catalyst 
for activation of nitroalkene to form nitronate as intermediate. This result initiated our 
interest in other functional group transformation studies based on our proline catalysis 
system. 
 
Scheme 10. Lewis Base Catalyzed Cascade Conjugated Addition
NO2
CH3R
+
O
R1
R2
20% L-proline, 1eq. NaN3
R
NO2
R1
R2
O
R CH3
NO2 LB catalyst NO2H3C
R
LB
Electrophile
R E
NO2
15 examples, 70-90%
DMSO, rt, 3h
 
 
2.2 Design of isoxazoline N-oxide synthesis 
    The 1,3-dipolarphile can be generated by addition of Lewis base to β-alkyl nitroalkene. 
We envisioned that followed by [3+2] cycloaddition with alkene, isoxazoline N-oxide 
will be obtained in high atomic efficiency. To evaluate this design, the one pot cascade 
reaction of β-alkyl nitroalkene and vinyl ethyl ether was first applied. 
 
3. Results and Discussion 
3.1 Reaction condition screening 
    The reaction result of β-methyl, phenyl nitroalkene 1a and vinyl ethyl ether 2 are 
shown in Scheme 11. 
 
Scheme 11. Cycloaddition of Nitroalkene and Vinyl Ether
NO2
CH3Ph
+
OEt L-Proline 20%
DMSO, 70oC
    additive
N O
O
Ph Ph
Additive YieldEntry
1
2
3
4
None
1 eq. NaOAc
1 eq. BF3-THF, 1 eq. NaOAc
1 eq. BF3-THF
0%
5%
56%
0%
CH3
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    With only proline as catalyst, no cyclization product was observed, even at 70oC. The 
addition of one equivalent NaOAc help to give isoxazoline N-oxide as single trans isomer 
product in trace yield. NaOAc might perform as buffer tuning reagent for this 
transformation. Since OEt group was eliminated during the process, we then test the 
condition with the presence of one equivalent BF3-THF and NaOAc along with 20% of 
L-proline at 70oC. Within 10 hours, the yield of isoxazoline N-oxide was increased to 
56%. Meanwhile with only BF3-THF and L-proline, the reaction would not happen. It is 
expected that the nitronate formed from Lewis base addition to the nitro alkene is crucial 
for the sequential [3+2] cycloaddition. BF3-THF was used as a Lewis acid to bind with 
oxygen, made OEt a better leaving group for the following elimination. 
 
    With the leaving group hypothesis in mind, we then postulated a better leaving group 
on alkene as acetate. The reaction between nitroalkene 1a and vinyl ether 4a was tested. 
The results are given in Table 1. 
 
NO2
CH3Ph
+
OAc N O
O
Ph PhCH3
N
H
Rcat.
1a 4a 3a
Table 1. Screening of the Reaction Conditions
 
Entry cat. base solvent temp time(h) conv(%) yield(%)
1 none none DMSO 70oC 8 0 0 
2 none NaOAc DMSO rt 8 90 0 
3 none NaOAc DMSO 70oC 8 95 5 
4 cat.-1 none DMSO rt 24 37 19 
5 cat.-1 NaOAc DMSO rt 8 99 88 
6 PPh3 NaOAc DMSO rt 8 95 8 
7 NMI NaOAc DMSO rt 8 87 9 
8 DMAP NaOAc DMSO rt 8 85 7 
9 cat.-2 NaOAc DMSO rt 8 81 20 
10 cat.-2 NaOAc/ 
HOAc(20%)
DMSO rt 8 88 29 
11 Glycine NaOAc DMSO rt 8 90 54 
12 cat.-3 NaOAc DMSO rt 8 99 45 
13 cat.-1 Cs2CO3 DMSO rt 8 99 46 
14 cat.-1 NaOtBu DMSO rt 8 99 43 
15 cat.-1 Et3N DMSO rt 10 95 40 
16 cat.-1 NaOAc MeOH rt 8 98 22 
17 cat.-1 NaOAc THF rt 24 15 5 
18 cat.-1 NaOAc CH3CN rt 24 10 trace 
 
Reactions were carried out with 1a:4a:cat. = 1:2:0.2. Concentration is 0.2 M of 1a. 
Conversion was based on the consumption of 1a by NMR. Yield was determined by 
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NMR. Cat.-1: R = COOH; cat-2: R = H; cat-3: R = CH2NHC(S)NHAr. (Ar = 2,3-di-CF3-
Ph). 
 
    As shown in Table 1, without L-proline as Lewis base, the thermo [4+2] cycloaddition 
was not observed even at higher temperature (Entry 1). This is probably due to the steric 
hindrance of the 2,2-disubstitued nitroalkene 1a. The combination of proline as catalyst 
and NaOAc as additive was critical for good yield (Entry 2-5). With only NaOAc’s 
presence, significant polymerization of 1a was observed and very small amount of 3a 
was produced at high temperature (Entry 3). This result suggested that rather than the 
base deprotonation of the methyl group in nitroalkene, nucleophilic addition by a Lewis 
base was the key step to form product 3a. Phosphorus nucleophilic catalyst and tertiary 
amines resulted in significant amount of polymerization. Only secondary and primary 
amines were found as the effective catalysts for this reaction. Interestingly, glycine gave 
better yield than pyrrolidine (Entry 9 and 11), even when 20% of acetic acid was added to 
mimic the basicity of the proline/NaOAc condition (Entry 10). This effect was further 
emphasized when thiourea modified proline was applied (Entry 12). Both cases got 
reasonable good yields. The results strongly imply the formation of an intramolecular H-
bond of the amino acid activated nitronate intermediate, which may lead to future 
enantioselective reactions. Other bases and solvents have also been investigated. NaOAc 
as an additive in DMSO was identified as the best condition.  
 
3.2 Substrate scope 
    Various nitroalkenes and vinyl esters were applied to investigate the substrate scope. 
The results are shown in Table 2. 1 (1.0 equiv), 4 (2.0 equiv), L-Proline (20%), and 
NaOAc (1.0 equiv) were dissolved in DMSO (0.2M) and stirred at room temperature for 
10 hours. Yields were isolated yields. 
 
Table 2. Isoxazoline-N-oxide Synthesis Substrate Scope
R1
NO2 OAc
R3
+
R2
20% L-proline, 1 equiv NaOAc
DMSO, rt, 10h
N O
O
R1 R1
R3
R2R2
1 4 3  
 
Entry Nitroalkene Vinyl Ester Product Yield 
 
 
1 
 
NO2
CH3Ph  
 
OAc
 
N O
Ph CH3 Ph
O
 
 
 
88% 
 
 
2 
 
NO2
CH3Ph  
 
OAc
Me  
N O
Ph Ph
O
CH3  
 
 
76% 
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3 
 
NO2
CH3Ph  
 
OAc
Et  
N O
Ph Ph
O
Et  
 
 
71% 
 
 
4 
 
NO2
CH3Ph  
 
 
OAc
Ph  
N O
Ph Ph
O
Ph  
 
 
65% 
 
 
 
5 
 
NO2
CH3
Me  
 
 
OAc
 
N O
CH3
O
Me Me  
 
 
 
83% 
 
 
 
6 
 
NO2
CH3
Me  
 
 
OAc
Ph  
N O
O
Me Me
Ph
 
 
 
 
66% 
 
 
 
7 
 
NO2
CH3
Cl  
 
 
OAc
 
N O
CH3
O
Cl Cl  
 
 
 
77% 
 
 
 
8 
 
NO2
CH3
Cl  
 
 
OAc
Me  
N O
O
Cl Cl  
 
 
 
58% 
 
 
 
9 
 
NO2
CH3
 
 
 
OAc
 
N O
CH3
O
 
 
 
 
75% 
 10
 
 
 
10 
 
NO2
CH3
 
 
 
OAc
Ph  
N O
O
Ph
 
 
 
 
61% 
 
 
11 
 
NO2
Ph
CH3  
 
OAc
 
N O
Ph CH3 Ph
O
H3C CH3
 
 
 
75% 
 
 
12 
NO2
 
 
OAc
 
N O
CH3
O
 
 
 
87% 
 
 
13 
NO2
 
 
OAc
Me  
N O
O
CH3  
 
 
80% 
 
 
14 
NO2
 
 
OAc
Et  
N O
O
Et  
 
 
74% 
 
 
15 
 
NO2
 
 
 
OAc
Ph  
N O
O
Ph  
 
 
70% 
 
 
 
16 
NO2
 
 
OAc
 
N O
CH3
O
 
 
 
72% 
 
 
17 
NO2
 
 
OAc
Me  
N O
O
CH3  
 
 
65% 
 
 
18 
 
NO2
 
 
OAc
 
N O
CH3
O
 
 
 
55% 
 11
    The substrates include aryl-alkyl and dialkyl (both cyclic and acyclic) nitroalkenes. A 
severe polymerization was observed when using monoalkyl or monoaryl nitroalkenes as 
the starting material, giving only trace amount of desired isoxazoline product. Different 
β-substituted vinyl esters were also tested for this transformation, giving easy access to 
the C-4 position of product. Notably, all cases give trans diastereomer as the only product.  
 
3.3 Deuterium-labeling study 
 
To further elucidate the reaction mechanism, especially the stereoselectivity, deuterium 
exchange study have been performed. When recharging product 3a into the reaction 
condition under the presence of D2O, no deuterium exchange was observed from NMR, 
which implied that no epimerization of the C-5 stereogenic center occurred after 3a was 
formed. Therefore, the cyclization should be the key step that account for the formation 
of the single trans isomer. A reaction between 1a and 2a was then performed in the 
presence of D2O. As expected, deuterium exchange was observed on the C-5 position 
along with the C-4 methyl groups and two alkene groups (Scheme 12). Notably, no 
deuterium exchange was obtained on the C-4 hydrogen. Therefore, a mechanism is 
proposed. 
 
N O
Ph CH3 Ph
O
L-Proline 20%, NaOAc
DMSO/D2O 5:1, rt, 24h
     no deuterium 
exchange observed
NO2
Ph
OAc L-Proline 20%, NaOAc
DMSO/D2O 5:1, rt, 10h
N O
Ph CD3 Ph
OD
D
H
D
D
D
Scheme 12. Deuterium Labeling Study
 
 
3.4 Proposed mechanism 
 
    As illustrated in Scheme 13, the reaction between 1a and proline produced nitro 
carbanion intermediate B. It is likely that B underwent a [3+2] dipolar cycloaddition with 
vinyl ester, forming five-membered heterocyclic intermediate C. However, the 
transformation from B and vinyl ester to F can went through different mechanisms, 
where the cycloaddition and retro-electro cycloaddition is just one possible pathway. And 
the formation of diene F is confirmed during our further study. The second nucleophilic 
addition of nitronate B to diene F underwent a Mukaiyama-type transition state, gave the 
corresponding  intermediate G. After the fast epimerization of the C-5 proton, the 
cyclization of H gave the trans isomer as the only product. The fact that no proton 
exchange occurred on the C-4 position was consistent with the proposed mechanism. 
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Me Ph
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H
H
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-H+
Me
N
Ph
NO2
H
N O
AcO
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HO
OAcHN
Me
Ph
A nitronate B C
NH
N O
HO
OAcHPh
-HOAc
N
HO
Ph
ring openingPh
NO2
Me
Me
N
Ph
NO2
H
nitronate B
Ph
NO2
Me
H
NO2
H
Ph
Ph
N
Me
H
R
H
NO2
O
O
NH
TM
Diene F E D
-NO2Ph
N
Me
H
H
NO2
O
O
Ph
G H
epimerization
Scheme 13. Proposed Mechanism for the Formation of Isoxazoline-N-oxide
O
 
    If the reaction is carried out under deuterium environment, D-H exchange could 
happen in each equilibrium, such as in the intermediate B and F. However the C-4 H 
derived from starting material vinyl ester will stay the same, since it was not 
deprotonated during the whole process. 
 
N O
D
Ph
O
H
H
H
OAc
-HOAc
ring opening
N
O O
Ph H
H
H
N
O O
D
LB
Ph
OAc
3+2
N
O O
Ph
CD3
H
Scheme 14. Explaination of Deuterium Study
 
 
3.5 Further functional group transformation 
    As a very useful synthon, the isoxazoline N-oxide can be readily converted into other 
synthetically attractive building blocks. It can be oxidized to isoxazolidine or reduced to 
β-hydroxy amine through easy steps as shown in scheme 15.  
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Scheme 15. Synthetic Application of Isoxazoline-N-oxide
N O
Ph CH3
O
Ph
P(OMe)3
N O
Ph CH3 Ph
81% yield
N O
Ph CH3
O
Ph
MW, 160oC
DMF, 71% yield
N O
Ph CH3 Ph
N O
CH3
1. LAH, THF
2.Ac2O, Et3N, DCM CH3
AcHN OH
65% yield
single diastereomer  
 
4. Conclusions 
    In conclusion, a catalytic cascade one-step synthesis of isoxazoline N-oxide was 
developed. A large variety of nitroalkenes and vinyl esters were suitable for this 
transformation, giving only trans isomer with good to excellent yields. Mechanistic 
studies revealed intramolecular nitronate cycloaddition as the rate-determining step. This 
strategy provided not only a new approach for the construction of substituted isoxazoline 
derivatives but also further evidence of secondary amine nucleophilic activation of 
nitroalkene, an alternative path of proline catalysis. Other secondary/primary amine-
promoted nitroalkene cascade reactions are currently under investigation in our group. 
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Part II 
Development of 1,2,3-Triazole-Borane Complex as 
Effective Reagent for Aldehyde/Ketone Reductive 
Amination 
1. Introduction 
1.1 Borane complexes and their reactivity 
    The application of boron reagents in organic synthesis led to Herbert C. Brown being 
awarded the Nobel Prized in Chemistry in 197915. Since then, this relatively rare element 
has remained on the cutting-edge of modern synthetic chemistry. 
 
    Borane is well known for the hydroboration of alkenes and alkynes. It’s an avid 
electron-pair acceptor, having only six valence electrons on boron. Borane complexes can 
be described as Lewis acid-base adducts of acidic BH3 with different bases, include 
ethers, sulfides, phosphines and amines (Scheme 16).  
 
O BH3
R
R
S BH3
R
R
P BH3
R
R
R N BH3
R
R
R
Scheme 16. Typical Borane Complexes
 
 
    Borane-tetrahydrofuran (BTHF) and borane-dimethyl sulfide(BMS) are often used as a 
borane source. Both reagents are in solution, and are therefore easier to handle than 
gaseous diborane. BTHF and BMS are widely used in hydroboration. They also offer 
interesting applications in the reduction of various functional groups, such as the direct 
reduction of amides to amines (BTHF) and carboxylic acids to alcohols (BMS). An 
example of BTHF is in the hydroboration of an alkene followed by oxidation, 
regioselectively gave the desired anti-Markovnikov alcohol16 (Scheme 17). 
 
Scheme 17. Hydroboration of Alkenes by Borane-THF
R
H
H
OMOM
OTBS
1. BTHF
2. H2O2, NaOH R
H
H
OMOM
OTBSHO
 
    EPIX Medical has used BTHF for the reduction of an amide in the synthesis of an 
injectable vascular contrast agent. They optimized conditions to minimize reduction of 
the Boc protecting group17 (Scheme 18). 
 
Scheme 18. Reduction of Amide by Borane-THF
HN
N
H
O
NH2HO
Boc
BTHF
0-23oC HN
N
H
NH2HO
Boc  
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    Compare with BTHF, the distinct advantage of borane-dimethylsulfide is its stability, 
allowing the production of BMS in high concentrations(~10M). Oxidation after the 
reaction effectively removes the dimethylsulfide component. A nitrile reduction18 is 
shown in Scheme 19. 
 
Scheme 19. Nitrile Reduction by Borane-Dimethylsulfide
OTrO CH2CN
H
HO
BMS, THF
reflux
OTrO CH2CH2NH2
H
HO
Tr: triphenylmethyl  
 
    Further applications were developed in the recent years: In 2008, Attlesey in BASF 
synthesized a new kind of borane complexes with substituted THF ethers and applied 
them as reagents for asymmetric reduction of acetophenone19. In 2004, Santhosh’s group 
developed recyclable fluorous borane-sulfide compounds to overcome the extremely 
volatile and environmentally unacceptable Me2S associate with BMS20. In addition to 
their usefulness as a regio- and chemoselective reducing agent, BTHF and BMS are often 
used with chiral oxazaborolidine catalysts for asymmetric ketone reduction. The most 
famous example is CBS catalyst21,22 (Scheme 20). 
 
Scheme 20. Asymmetric Reduction of Ketones by Chiral CBS and BTHF/BMS
O
F
O BMS, 5%
    toluene, 20oC
>99% yield,95% ee O
F
OHN B
O
Me
Ph
Ph
H
CH3
O BTHF, 2.5% N B
O
H
Ph
Ph
H
         THF, 23oC
99.9% yield, 94.7% ee
CH3
HO H
 
 
    Phosphine-borane complexes were first reported by Burg and Wagner23 in 1953. In 
2004, Zhou and Manulty reported a simple, general, economical synthesis of phosphine-
borane complexes using sodium borohydride as the borane source24 (Scheme 21). These 
phosphine-borane complexes can be used in the synthesis of soluble hindered phosphine 
ligands and polymer-linked hindered phosphines. 
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P
R2
R1 R3
1. NaBH4, THF
2. HOAc, THF
P
R2
R1 R3
BH3
Scheme 21. Synthesis of Phophine-Borane Complexes
R1, R2, R3 = alkyl
 
 
    Posphine-borane can also be used in the synthesis of biologically active phosphorus 
heterocycles using a ring closure enyne metathesis methodology25 (Scheme 22). 
  
Scheme 22. Ring Closure Metathesis of Phosphine-Borane Complexes
O
P
O
BH3
16h, DCM, reflux
Ru
Cl
Cl
PCy3
Ph
NN MesMes
1%
P
OO
BH3
 
 
    Another application of phosphine-borane is the synthesis of P-chirogenic phosphines26. 
The oxazaphospholidine boranes were prepared by heating bis(dimethylamino)-
phosphine in toluene with ephedrine followed by addition of BMS(or BTHF). A regio- 
and stereoselective ring-opening of the heterocycle leading to an aninophosphine borane. 
Finally, the complex was easily transformed into the desired product by subsequent 
highly stereoselective reactions involving electrophilic or nucleophilic strategies (Scheme 
23). 
 
Scheme 23. Synthesis of P-Chirogenic Phosphorus via Phosphine-Borane
R1P(NMe2)2 +
HO
N
H
Ph
Me
Me
BH3 O
N
H
P
H3B
R1
Ph
Me
LiR2
N
Me
P
HO
Ph
Me
R1
R2
H3B LiR3 P
R3R2
R1
 
 
    The first amine-borane complex (Scheme 24) was reported in 1937 and was prepared 
by the direct reaction of diborane with trimethylamine27. Since then different types of 
amines have been used to prepare amine-boranes. 
 
Me
N
Me
Me
+ B2H6 N B
Me
Me H
Me
H
H2 2
Scheme 24. First Synthesis of Amine-Borane Complex
 
 
    Triethylamine borane can be used in the reduction of carboxylic acid, ketone and 
aldehyde groups at 80oC without solvent. In addition, triethylamine-borane has been 
effectively used in the reductive amination28 (Scheme 25). 
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Scheme 25. Reductive Amination by Triethylamine Borane
HN
H
NH
NH
Et
Me
Ts
2HCl + H
O
H
O
N BH3
Et
Et
Et
MeOH/H2O, rt
HN
H
Ts N
N
Me
Et
 
 
    Aldyhydes can be selectively reduced in the presence of ketones by using tert-
butylamine borane as the reducing agent. Tert-butylamine borane is also effective for 
reductive aminations, and for the reduction of enones at room temperature to give allylic 
alcohols. The following reaction shows tert-butylamine borane in a reductive ring closure 
for the synthesis of a benzazepine drug intermediate29. 
 
Scheme 26. Reductive Ring Closure by tert-Butylamine Borane
Cl
MeO
N
OMe
1. MeSO3H, 60oC
N BH3
H
H
t-Bu , < 15oC2.
OMe
Cl
MeO
N
 
 
    N,N-diethylaniline borane is a moderately reactive amine borane as a neat liquid. It is 
moisture sensitive and must be used in aprotic solvents. When combined with CBS 
catalyst, N-N-diethylaminlin is an excellent borane source for the enantioselective 
reduction of ketones30. For example, in the scale-up of a key intermediate of formoterol, a 
bronchiodilator, N,N-diethylaniline borane was used as the borane source in the 
enantioselective ketone reduction31 (Scheme 27). 
 
Scheme 27. Asymmetric Reduction of Ketones by Diethyaniline Borane
BnO
NO2
O
Br N BH3
Et
Et
5%
NH2
OH
, THF
BnO
NO2
Br
OH
 
 
    Pyridine borane (PYB) can be used to reduce oximes to the corresponding hydroxyl 
amines32 (Scheme 28). Reductions of oximes take places in the presence of other 
functional groups such as esters, nitriles, amides, and alkyl halides. Pyridine borane can 
also be used for reductive aminations. 
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R N
OH
1. N BH3
2. ClCO2CH3
R N
CO2CH3
OCO2CH3
Scheme 28. Reduction of Oximes by Pyridine Borane
 
 
    Reduction of β-keto sulfones with pyridine borane in the presence of TiCl4 resulted in 
ketone reduction primarily via a titanium chelated intermediate yielding erythro-β-
hydroxy sulfones33. 
 
O
Me
SO2Ph
Ph
PYB, TiCl4
DCM Me
SO2Ph Me
SO2Ph
OH
Ph Ph
OH
+
95              :               5
Scheme 29. Reduction of Ketones by PYB and TiCl4
 
 
    2-picoline borane is a valuable reagent for reductive aminations. The imine group is 
reduced by 2-picoline borane to an amine, while leaving cyano and chloro functionalities 
unaffected. Aromatic ketones can be aminated quite easily with 2-picoline 
borane34(Scheme 30). The reduction proceeds rapidly when conducted in methanol, water 
or even without solvent to give secondary amines in excellent yields. 
 
Scheme 30. Reductive Amination by 2-Picoline Borane
N
H
+
O
N BH3
MeOH/AcOH (10:1)
rt, 1h
N
 
 
    Besides synthetic applications, amine-borane complexes are widely used in industry. 
For example, amine-boranes can perform as stabilizers and purifiers, fuel additives, 
photographic reagents, polymerization catalysts, and chemical plating agents35. In 
pharmaceutical areas, borane complexes of α-amino acids, aromatic, aliphatic and 
heterocyclic amines, nucleosides possess a wide range biological activities including 
antineoplastic, antiviral, hypolipidemic, anti-inflammatory activities, anti-osteoporotic 
and dopamine receptor antagonist activities36. 
 
    After the year 1995, two new kinds of borane complexes—metal borane complex and 
N-heterocylic carbene borane complex, have raised unceasing interests in the research 
field. The first reports on the existence of  metal-boron bonds were published in the 
1960s37, however, the identity wasn’t confirmed until recently. In the metal borane 
complexes, borane forms a fourfold coordination with transition metal. The first 
structurally authenticated borane complexes, namely the metallaboratrane derivatives 
[M{B(mt)3(CO)(PPh3)] (1: M = Ru, 2: M =  Os; mt = 2-sulfanyl-1-methulimidazole) was 
prepared by [M(R)Cl(CO)-(PPh3)2] with Na[HB(mt)3] (Scheme 31)38. Different metal-
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boryl complexes were prepared as well include dihaloboryl39, asymmetric haloboryl40, 
and iminoboryl complexes41 (Scheme 32). Further experimental and theoretical studies of 
the bonding descriptions are going on. Their potential application in stoichiometric or 
catalytic reactions is likely to emerge shortly. 
 
M
Cl PPh3
Ph3P CO
R
Na[HB(mt)3]
-RH
B
M
N
SN
N N
S
N
PPh3
S
N
CO
Scheme 31. Synthesis of zero-valent metallaboratranes
M = Ru, R = CH=CHCPH2OH
M = Os, R = Ph  
 
Ir
Ph3P PPh3
F2B BF2
CO
BF2
Fe B
OC
OC
NMe2
Cl
Pd
PCy3
Br
PCy3
B N SiMe3
Scheme 32. Examples of Dihaloboryl, Asymmetric Haloboryl, and 
                    Iminoboryl Complexes
 
 
    The search for simple, non-toxic, non-explosive compounds to mediate free-radical 
synthesis has led to a great deal of interests in organic chemistry. Recently, a new 
direction was developed from the research groups of Fensterbank, Lacote, Malacria, and 
Curran, who described a marriage of organoborane chemistry with N-heterocyclic 
carbenes. A large variety of scaffolds, including imidazolium, triazolium, and thiazolium 
derivatives can be used as NHC ligands42 (Scheme 33). The heteroatom donor groups 
remove the degeneracy of the carbine orbitals and thus enhance the nucleophilicity of the 
carbon atom. Study shows that the NHC-borane complexes have weakened B-H bonds so 
that they are better H donors than amine-boranes or phosphine-boranes. The reactivity 
was tested as radical reducing reagents with a series of secondary and benzylic xanthates. 
With AIBN as initiator, reduced products were isolated in reasonable yields43 (Scheme 
34). Development of practical stereoselective radical reduction protocols by NHC-Borane 
reagents is under investigation. 
 
Scheme 33. N-Heterocyclic Carbene-Borane Complexes
N S
BH3
Ph
N
N
N
Ph
BH3
N N
BH3
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Scheme 34. Reduction of a Secondary Hexenyl Xanthate with NHC-Borane
O
S SMe
BnO 5
N
N
N
Ph
BH3
AIBN, benzene, reflux BnO 5
(NHC-BH3)
5-exo
BnO 5
NHC-BH3BnO 5
H
+NHC-BH2
 
 
1.2 Reductive amination by different boranes 
 
    One-pot reductive amination is one of the most useful and versatile methods for the 
preparation of amines in chemistry and biology44. The reaction involves the initial 
formation of addition product as an aminol intermediate or carbinol amine, which under 
the suitable reaction conditions dehydrates to form an imine. The imine on protonation 
forms an iminium ion that subsequently reduced to the respective alkylated amine by a 
hydride reagent 45(Scheme 35). The amines, thus obtained are very useful in industry that 
have found wide-spread applications as intermediates for pharmaceuticals, dyes, resins, 
fine chemicals, solvents, textile additives, disinfectants, rubber stabilizers, corrosion 
inhibitors, and in the manufacture of detergents and plastics. The reductive amination 
possess several advantages in organic synthesis, such as one pot reaction, mild reaction 
conditions, wide commercial availability of substrates, use of economy-friendly reagents 
and so on. However, the reductive amination sometimes is associated with limitations in 
terms of functional group tolerance, side reactions and reaction conditions. Catalytic 
reduction is incompatible with compounds having other reducible functional groups such 
as multiple bonds including cyano, nitro groups. As a result, the choice of the reducing 
agents is very critical to avoid side reactions and toxicity of the reaction condition.  
 
Scheme 35. Mechanism of Reductive Amination
O
R2R1
N
H
R4R3
R3
R4HO
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R4R2
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R4
H- H2O
H2O
+
iminium ion alkyl amine  
 
    Reductive amination is widely used as the synthetic strategy to synthesize biologically 
active molecules and synthetic intermediates. Some applications are shown below. 
 
    Pyrrolizidinone amino acids are rigid dipeptide surrogates in which the peptide 
backbone is constrained within a fused 5,5-bicyclic structure. Enantio pure (3S, 5R, 8S)-
3-[N-(Boc) amino]-1-aza-bycyclo [3.3.0] octan-2-one 8-carboxylic acid was synthesized 
via multi-step process involving reductive amination as a key step. In the reductive 
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amination, hydrogenation of diamino substrate with Pd-C as catalyst in 9:1 EtOH/AcOH 
proceeded by cleavage of the phenylfluorenyl groups, intramolecular imine formation, 
protonation, and hydrogen addition to the iminium ion intermediate (Scheme 36)46. 
 
Scheme 36. Synthesis of Pyrrolizidinone Amino Acid via Reductive Amination
O
CO2tBu
NHPhFBuO2C
PhFHN
t
H2, Pd/C
AcOH, EtOH/THF HN
NH2BuO2Ct
H
CO2tBu
+
HN
BuO2Ct
H
CO2tBu
N
NH2BuO2Ct
CO2tBu
HN
NH2BuO2Ct
CO2tBu
-NH3
N
BuO2Ct
CO2tBu
O
BocHN
H
COOR
 
 
     Large alkyl substituents in proteins can be introduced by reductive amination to 
enhance the hydrophobicity. The free aldehyde form of reducing sugar has been coupled 
to protein by reductive amination47. The reactions of hemoglobin with glucose and 
glyceraldehydes have been studied in detail in order to understand its nonenzymatic 
glycosylation. Without the presence of reducing agent, slow Amadori rearrangement 
happens to give ketoamine as product (Scheme 37). 
 
Scheme 37. Reductive Amination of Sugar and Protein
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    In history, different boranes and borohydrides are used for reductive amination. 
Decaborane, a mild hydride reagent, has successfully been used by Yoon48 in reductive 
amination of carbonyl compounds to respective amines in moderate yields (Scheme 38). 
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Scheme 38. Reductive Amination by Decaborane
O
R2R1
+ R3NH2
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    Sodium Borohydride (NaBH4) is known to reduce imines in the same manner as it 
reduces carbonyl group in aldehydes and ketones49. However, its application is limited, as 
it reduces other reducible functionalities present in the same molecule. In order to 
eliminate the possibility of any other carbonyl group in being reduced to alcohol, it is 
necessary to convert the carbonyl group completely to imine first, which refers as an 
indirect reductive amination. Weak electrophilic carbonyl groups, poor nucleophilic 
amines and sterically hindered reactive centre do not favor the completion of imine 
formation. In those cases, NaBH4 by itself won’t give good results. Different NaBH4 salts 
are developed to solve the problems. 
 
a. Zinc salt: ZnCl2 and Zn(CF3COO)2 in an inert solvent such as THF yielded the amines    
from aldehydes in high yields via the in-situ formation of Zn(BH4)250. 
 
b. Titanium salt: TiCl4 and Ti(Oi-Pr)4 can be used to promote abstraction of water during 
imine formation51. Ti(Oi-Pr)4-NaBH4 has been used by Bhattacharya in such reactions52 
(Scheme 39). 
 
Scheme 39. Reductive Amination by Ti(IV) Isopropoxide-NaBH4
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c. Nickle salt: Nickel boride(NiCl2-NaBH4) was generated in situ from nickel chloride 
hexahydrate and sodium borohydride in Sarma’s group. It was used for reductive 
amination of aldehydes and ketones. Unlike other borane reagents, nickel boride is also 
well suited to α, β-unsaturated ketones53. 
 
d. NaBH4-H3PW12O4054, NaBH4-guanidine hydrochloride55, NaBH4 wet clay-
microwave56, NaBH4 in micellar media57, borohydride exchange resin58 were also 
introduced for the efficient and selective reductive amination. 
 
    Sodium cyanoborohydride (NaBH3CN) has been extensively used in reductive 
amination with remarkable selectivity59. The advantages of NaBH3CN include its 
stability in relatively strong acidic conditions (pH = 3), its solubility in hydroxylic 
solvents, and its different selectivity at different pH values. Those unique functions allow 
a convenient direct reductive amination by sodium cyanoborohydride for many substrates. 
Similar cyanoborohydride reagents were also developed, such as LiBH3CN60, (n-
Bu)4NBH3CN61, ZnCl2-NaBH3CN62, Ti(Oi-Pr)4-NaBH3CN63, Mg(ClO4)2-NaBH3CN64 
and so on. 
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    In 1996, Abdel-Magid reported the comprehensive study of direct and indirect 
reductive amination by sodium triacetoxyborohydride (NaBH(OAc)3) as a mild reducing 
agent65. Aliphatic acyclic and cyclic ketones, aliphatic and aromatic aldehydes, primary 
and secondary amines including a variety of weakly basic and nonbasic amines are the 
effective substrates during reductions with NaBH(OAc)3. Limitations include reaction 
with aromatic and unsaturated ketones and some sterically hindered ketones and amines. 
Acetic acid has been used as co-catalyst in ketone reactions. The  procedure can be 
carried out in the presence of acid sensitive functional groups such as acetals and ketals, 
it can also be carried out in the presence of reducible functional groups such as C-C 
multiple bonds, cyano and nitro groups. In comparison with other reductive amination 
reagents such as NaBH3CN, pyridine-borane, and catalytic hydrogentation, NaBH(OAc)3 
gave better yields and less side products. 
 
    Spirocyclic bis-azetidines, an interesting system has been synthesized by the reductive 
amination of chloro aldehyde with amines through initial formation of aryl amine with 
NaBH(OAc)3 followed by cyclization66 (Scheme 40).  
 
Scheme 40. Reductive Amination by NaBH(OAc)3
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    Zinc borohydride (Zn(BH4)2)67, Zn(BH4)2-ZnCl268, and Zn(BH4)2-silica gel69 were also 
utilized for reductive amination of aldehydes and ketones. Recently, Alinezhad’s group 
have reported thermally stable Zn(BH4)2-N-methylpiperidine for efficient and 
chemoselective reductive amination under neutral conditions by adding 10% of 
hydrochloric acid in methanol70.  
 
    Firouzabadi has used dichloro-bis(1,4-diazabicyclo[2.2.2] octane) tetrahydroborato 
zirconium (Zr[(BH4)2Cl2(dabco)2]) for the successful reduction of imines, enamines, 
reductive amination of aldehydes and ketones, and reductive methylation of amines71. 
This compound is stable under mild aqueous acidic conditions (pH 4-6) and survives in 
water for several days without losing its reducing ability. 
 
    Bhanage developed a direct reductive amination protocol for aldyheds/ketones using 
bis(triphenylphosphine) copper(I) tetrahydroborate as a novel reducing agent in the 
presence of sulfamic acid. The reagent chemoselectively reduces the imine moiety 
without affecting other reducible functionalities such as chloro, nitro, cyano and 
methoxy72. 
 
    Besides borane metal salts, amine-borane complexes were also used as the reductant in 
reductive amination. Seo developed a reductive amination of terminal aldehyde 
carbohydrate with thiol amine by using the  reductive coupling reagent dimethylamine 
borane. Later on the thiol amine was oriented immobilized onto a gold surface73 (Scheme 
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41). This application was useful for the studies of carbohydrates-biomolecule interactions 
and carbohydrate sensor or array development for diagnosis and screening. 
 
Scheme 41. Reductive Amination by Dimethylamine Borane
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    In 1995, DiMare reported in situ reductive amination with different amines and 
carbonyl compounds using methanolic pyridine-borane (PYB) and molecular sieves74. 
Usually pyridine-borane of commercial origin is utilized without further purification. Due 
to its instability to heat and violent decompositions, its industrial application is not 
recommended. 
 
    In 2004, Kikugawa reported one-port reductive amination of alkehydes and ketones 
with amines using 2-picoline-borane (PICB), a cheap and commercially available 
reducing agent. It is an alternative to NaBH3CN and pyridine-borane but superior because 
of its commercially availability, crystalline nature and relatively better stability. 
MeOH/H2O has been used as solvent for the reactions and neat conditions also works. 
The reaction in water offers a great opportunity for green chemistry. 
 
    Very recently, Coleridge reported 5-ethyl-2-methylpyridine borane (PEMB) complex 
as a useful reagent for reductive aminations in methanol or neat conditions75. Two of the 
three hydrides on PEMB are effectively utilized maximizing the economy of the 
reductant. 
 
    Tributyl tin hydride and silicone hydride derivatives, such as Bu3SnH, n-Bu2SnClH-
HMPA, Et3SiH-TFA, Ti(Oi-Pr)4-polymethulhydrosiloxane, PhSiH3-Bu2SnCl2 , also 
promote effective reductive amination in chemo- and stereoselective manner76-78. 
Hantzsch dihydropyridine with 2% scandium triflate can perform as organo catalyst in 
reductive amination79. The reduction is completely chemoselective for aldyhyde-derived 
imines over ketone-derived ones (Scheme 42). MacMillan reported the first 
organocatalytic reductive amination, a biomimetic reaction that allows the asymmetric 
coupling of complex with chiral hydrogen-bonding catalysts and Hantzsch esters80 
(Scheme 43). They proposed that exposure of ketone and amine to a chiral hydrogen-
bonding catalyst81 results in an iminium species formation in presence of a suitable 
Hantzsch dihydropyridine in asymmetric manner82.  
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Scheme 42. Reductive Amination by Hantzsch Dihydropyridine
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Scheme 43. Asymmetric Reductive Amination by Hantasch Dihydropyridine (HDHP)
O
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1.3 Limitation and challenges of reducing agents 
 
    Although different reducing agents for reductive amination were well developed 
during the recent decades, most of them suffered some limitations. The industrial use of 
sodium cyano-borohydride is unattractive due to the toxicity and large excess needed. 
Sodium triacetoxyborohydride, although quite selective for reductive amination, has only 
one hydride per molecule so that sometimes more than five-fold excess is required for the 
transformation. Catalytic hydrogenation has limited use with compounds containing 
multiple C-C bonds or hydrogen sensitive functionalities in the substrates. Metal boranes 
are environmental unfriendly or even high toxic. Some amine-boranes works well, but the 
poor thermal stability or sensitivity toward moisture are the major drawbacks.  
 
2. Research Objective 
 
2.1 1,2,3-triazole overall view, structures and properties 
2.1.1 Synthesis of 4,5-disubstituted 1,2,3-(NH)-triazole 
 
    During the past 5 years, the 1,2,3-triazole compounds have been received considerable 
attention from different research fields such as material science83, chemical biology84, 
and medicinal chemistry85. This is due to the successful development of 1,2,3-triazole 
synthesis by Cu-catalyzed azide alkyne 1,3-dipolar cycloaddition system (referred as 
“click chemistry”) (Scheme 44)86. However, one limitation of the methodology is the 
deficient reactivity with unsubstituted azides, which makes the preparation of 1,2,3-
(NH)-triazole a challenge. 
 
Scheme 44. Preparation of 1,2,3-Triazoles via "Click Chemistry"
R1 + N3 R2
Cu(I)
"Click Chemistry"
N
N
N R
2
R1 H  
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    In 2008, our group developed a lewis base-catalyzed three-component cascade reaction 
for the synthesis of 4,5-disubstitued-1,2,3-(NH)-triazoles87. This strategy was based on 
the previous study of the nitronate formation with Lewis base addition to nitroalkene. 
Henry reaction of nitroalkene and aryl aldehyde catalyzed by L-proline can give 1,3-
diene as the key intermediate. With the presence of NaN3, diene was quenched to form 
1,2,3-(NH)-triazole product through cycloaddition (Scheme 45). A large number of aryl 
aldehydes and β-alkyl nitroalkenes were suitable for this transformation. Various 4,5-
disubstitued NH-triazoles can be efficiently synthesized in good yields from this mild 
cascade process. The modifications of the side chain can easily be carried out and used 
for further study (Scheme 46). 
 
Scheme 45. One Step Formation of 1,2,3-(NH)-Triazole
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Scheme 46. Side Chain Modification of 1,2,3-(NH)-Triazoles
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2.1.2 Synthesis of metal-triazole complex 
 
    Trizaoles are considered as potential good ligands in coordination with transition 
metals due to its better σ-donating nitrogen and π-receiving aromatic ring system. 
Recently, our group further confirmed the theory by having our 1,2,3-(NH)-triazoles to 
react with rhodium and gold cations to form complexes. 
 
    4,5-disubstituted NH-1,2,3-triazoles were used to coordinate with Rh(I) to form a new 
class of triazole-bridged [Rh(COD)(triazole)]2 complexes (Scheme 47)88. The crystal 
structures were studied by X-ray crystallography. These new complexes showed 
improved stability toward air and moisture. The reactivity was tested by typical Pauson-
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Khand reactions (Scheme 48). Interestingly, bonding sites can be switched to different 
nitrogens when C-4 substituted group varies. 
 
N
NH
N
Ph
KOH, MeOH, rt
[Rh(COD)Cl]2
Rh
N
N
NPh
Ph
N
Rh
N
N
Ph
Scheme 47. Preparation of [Rh(COD)(Triazole)]2 Complex
 
 
Scheme 48. Triazole-Rh(I) Complex Catalyzed Pauson-Khand Reactions
Ph
O 5% triazole-Rh(I), dppp 6%, xylene
CO 5 atm, 130oC, 80% yield
O
Ph
O
 
 
    A series of 1,2,3-triazole-Au(I) complexes were synthesized via similar method89. 
Structures were confirmed by X-ray crystallography. As we expected, they possessed 
better thermal and moist stability than literature reported Au catalysts. As a result, the 
challenging intermolecular internal alkyne hydroaminations were successful achieved at a 
higher reaction temperature, giving excellent yields with low catalyst loading (Scheme 
49). 
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Scheme 49. Triazole-Au(I) Catalyzed Intermolecular Hydroamination
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2.2 Design of triazole-borane synthesis 
 
Our interest in developing 1,2,3-triazole-coordinated complexes was initiated by our 
recent success with a metal-free 1,2,3-NH-triazole synthesis and post-triazole 
regioselective derivatization. Comparing with other N-heterocyclic aromatic compounds, 
1,2,3-triazoles possess unique functions include: high polarity and electron density on the 
nitrogen (more nucleophilic and less basic) allowing them to coordinate well with Lewis 
acids, while a lower LUMO in the aromatic ring enhanceing back bonding, giving stable 
triazole-metal binding. Triazole-Rh(I) and trizole-Au(I) complexes were prepared, 
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provided much better stability toward air, moisture and heat. Therefore, we wondered 
whether 1,2,3-triazoles could interact with Lewis acid borane to form effective triazole-
borane complex for further reduction application. 
 
3. Results and Discussion 
3.1 Synthesis of triazole-borane complex 
 
The reaction results of different triazoles with BH3-THF is shown in Table 3. 
 
R1
N
N
N
R2
R3 R1
N
N
N
R2
R3
BH3
1.1 equiv 1M BH3-THF
dry THF
6 7
Table 3. Preparation of Triazole-Borane Complexes
 
Triazoles Reaction Results Yield (%) 
N
NH
N
      6a 
 
complex mixtures 
 
n.d. 
N
N
N
CH3
     6b 
 
 
stable white solid 
N
N
N
CH3
BH3
N
N
N
CH3
6c 
 
no reaction 
 
- 
N
N
N
Ph
       6d 
 
 
stable white solid 
N
N
N
Ph
BH3  
N
N
N
Ph
 6e 
 
no reaction 
 
- 
N
NH
N
Ph       6f 
 
complex mixtures 
 
n.d. 
N
N
N
Ph
Ts
        6g 
 
complex mixtures 
 
n.d. 
N
N
N
Ph
Ph
  6h 
 
no reaction 
 
- 
 
7a,>99% 
7b, >99%
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    The reactions between NH-triazoles (6a and 6f) and BH3-THF gave complex mixtures, 
whose structure cannot be identified at this moment. This was probably due to the 
multiple nitrogen binding sites on the triazoles and possible formation of B-H-B 3c2e 
bond. The N-2 substituted benzyl triazoles (6c, 6e and 6h) indicated no complex 
formation even when treated at a higher temperature (50 oC). This lack of coordination 
was likely caused by the steric hindrance of the N-2 substituted groups. The 1,4-
disubstituted triazole 6g is the popular triazole derivative product prepared from “click-
chemistry”83. Unfortunately, the reaction between 6g and BH3-THF gave multiple 
complexes with low reaction rate (more than 12 hours at room temperature) and the 
complexes decomposed during attempt of isolation (Table 3). 
 
    In order to decrease the steric hindrance on the N-2 position, we examined the N-1 
substituted benzotriazoles 6b and 6d react with BH3-THF. To our great pleasure, the 
triazole borane complexes 7a and 7b were formed as white solids in nearly quantitative 
yields. The structure of 7a was confirmed by X-ray crystallography with BH3 bond on the 
N-3 position as expected. Notably, the triazole-boranes were very stable toward air and 
moisture and can even be purified by column chromatography. The complexes were also 
thermally stable as high as 80 oC (no decomposition). 
 
3.2 Reductive amination of aldehyde and condition screening 
 
    With these new triazole-boranes 7a and 7b in hand, we then explored their reactivity as 
reductants. The transformation that particularly interested us was the aldehyde and ketone 
reductive amination, a very important reaction in organic synthesis especially for 
biological related systems. As a very attractive approach for bio-elongation, the key 
concerns regarding “good” reductive amination reagents are: a) good chemoselectivity 
(selectively reduce imine rather than aldehydes and ketones); b) bio-compatibility 
(“green” reaction conditions), and c) stability in protic solvents. Among these factors, the 
hydride stability under acidic conditions is particularly challenging due to H2 formation.  
As a result, reductive amination of ketones is one extremely difficult task, since acid 
activation of ketone is often required for the effective imine formation. 
 
To evaluate the reactivity of triazole boranes, aldehyde 8a and aniline 9a were first 
applied as shown in Table 4.  
 
 
 
Cl
H
O
+
NH2
Cl
N
H
Triazole-Borane
solvent
Table 4. Condition Screening of Aldehyde Reductive Amination
8a 9a 10a  
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Entry Tria-Borane Solvent Temp Time(h) Yield(%) 
1 7a (0.7 eq.) CH2Cl2 rt 5 99 
2 7b (0.7 eq.) CH2Cl2 rt 3.5 99 
3 7b (0.7 eq.) DMSO rt 0.5 95 
4 7b (0.7 eq.) DMF rt 5 91 
5 7b (0.7 eq.) THF rt 15 min 72 
6 7b (0.7 eq.) Toluene rt 1.5 99 
7 7b (0.7 eq.) CH3CN rt 4 99 
8 7b (0.7 eq.) MeOH rt 2 99 
9 7b (0.7 eq.) neat rt 5 min 94 
10 7b (0.4 eq.) DCE rt 3 99 
11 7b (0.4 eq.) DCE 60oC 0.5 99 
12 7b (0.4 eq.) MeOH rt 1 48 
 
Reactions were carried out by mixing 8a (1.05 equiv), 9a (1.0 equiv), and 7 together 
under different conditions. The triazole boranes showed excellent reactivity toward 
aldehyde reductive amination in various solvents, giving near quantitative yields in most 
of the cases. Although both 7a and 7b were stable triazole borane complexes, 7b showed 
improved solubility in organic solvents. As a result, a slightly improved reaction rate was 
observed (entries 1 and 2). The reaction in THF gave lower yield, which was likely due to 
the solvent coordination with borane that led to side reactions. Notably, these new borane 
complexes indicated great stability in protic solvent MeOH or at a higher temperature 
(entries 8 and 11). Impressively, the reaction gave quantitative yield in DCE even with 
only 0.4 equiv of reductant (a slight increase of reductant was needed for protic solvent, 
entries 8 and 12). Considering that 1 equiv of water was produced in this process, the fact 
that only the theoretical limit amount (0.33 equiv) of borane was needed indicated the 
extremely high hydride transfer efficiency and superior stability of the triazole-borane 
reductants. Representative aldehydes and amines were applied as shown in Table 5. 
 
R1 CHO + R2
H
N
R3
7b
rt, DCE
R1 N
R3
R2
Table 5. Reductive Amination of Aldehydes
8 9 10  
 
Entry Aldehyde Amine T 
(h)
Product Yield 
(%) 
 
 
1 
Cl
H
O
 
NH2
 
 
 
3 
 Cl
N
H
 
 
 
99 
 
 
2 
MeO
H
O NH2
 
 
 
3 
MeO
N
H
 
 
 
99 
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3 H
O
 
NH2
 
 
 
3 NH
 
 
 
99 
 
 
4 H
O
Cl  
 
MeO NH2
 
 
3 
Cl
N
H
OMe
 
 
 
99 
 
 
5 H
O
Cl  
 
F NH2
 
 
 
6 
Cl
N
H
F
 
 
 
99 
 
 
6 H
O
Cl  
 
NH2
 
 
 
4 
 
Cl
N
H
 
 
 
95 
 
 
7 H
O
Cl  
 
NH2
MeO
 
 
 
4 
 
Cl
N
H
OMe
 
 
 
96 
 
 
8 H
O
O2N
 
 
NH2
MeO
 
 
 
3 
 
O2N
N
H
OMe
 
 
 
82 
 
 
9 H
O
Cl  
 
 
NH2  
 
 
4 
 
Cl
N
H
 
 
 
91 
 
 
10 H
O
Cl  
 
N
H  
 
 
4 
 
Cl
N
 
 
 
95 
 
 
11 H
O
Cl  
H
N
CH3
 
 
 
3 
Cl
N
CH3  
 
 
99 
 
 
12 H
O
 
NH2
 
 
 
3 NH
 
 
 
99 
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13 
N
H
O
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2 
N
N
H
 
 
 
99 
 
 
14 H
O
O  
NH2
 
 
 
3 NHO  
 
 
99 
 
 
15 H
O
S  
NH2
 
 
 
3 NHS  
 
 
99 
 
 
16 H
O
N
NH  
NH2
 
 
 
3 NH
N
NH  
 
 
93 
 
 
17 H
O
 
NH2
 
 
 
3 NH
 
 
 
95 
 
 
18 H
O
Cl  
H2N
 
 
 
3 
Cl
N
H
CH3
 
 
 
96 
 
    The results demonstrated that this transformation is suitable for a large variety of 
aldehydes (aromatic, aliphatic, unsaturated and heteroaromatic) and amines (aromatic, 
aliphatic and secondary amines). Excellent yields were obtained for almost all cases.  
Meanwhile, the benzotriazole by-product could be recovered in nearly quantative yield. 
 
3.3 Reductive amination of ketone 
   
    Encouraged by this success, we extended the investigation to ketones. Since acids were 
often required for the imine formation, 30% of AcOH was added as the catalyst (no 
reaction was observed without acid catalyst at room temperature for 24 hrs). Again, 
effective reductive amination of ketone was achieved using triazole-boranes with a 
slightly higher loading of reductant (0.8-1.2 equiv). Moreover, this ketone reductive 
amination could also be achieved by increasing the reaction temperature without further 
addition of acid catalyst (condition B). Reaction substrates are shown in Scheme 50. 
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B: 6h, 99%
A: 5h, 85%
B:4.5h, 87%
A: 5h, 47%
B: 3h, 96%
Scheme 50. Reductive Amination of Ketones
11 9 12
 
 
    As shown in Scheme 50, this reaction was suitable for primary amine, secondary 
amine and aniline. Meanwhile, the two different reaction conditions provided orthogonal 
approaches for sensitive substrates. For examples, in the synthesis of 12f, the furanyl 
ketone decomposed under acidic conditions. Therefore, using condition A gave 12f in 
less than 50% yields along with ketone decomposition by-products. Application of 
condition B could help to avoid the decomposition of ketone, giving 12f in excellent 
yield. The enone substrate has also been investigated (cyclohexenone). A mixture of 
different reduction products (including the desired allylic amine) was observed. The lack 
of chemo-selectivity was likely caused by the harsher conditions. Benzophenone also 
didn’t work well due to its large steric hindrance of the two phenyl groups. However, 
when compared with other reductants, triazole-borane showed much better stability and 
reactivity in different ketone examples.  
 
    Overall, to the best of our knowledge, the triazole-borane was by far one of the most 
efficient metal-free reagents for the challenging ketone reductive amination. With clear 
evidence for improved proton and thermal stability of TAB, we then applied this reagent 
to the unprotected amino acid reductive amination in water. 
 
3.4 Reductive amination of unprotected amino acids 
 
    To increase the solubility of amino acid in water, 30% Na2CO3 was added (Scheme 51).  
This modification helped the further evaluation of the triazole-borane reductant under 
basic conditions. As anticipated, good yields were obtained. Notably, this reaction 
tolerated functional groups that may potentially coordinate with borane, such as 
imidazole and sulfur (14b and 14c), which further enhanced the synthetic utility of the 
reductant. 
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Scheme 51. Reductive Amination of Amino Acid
 
 
3.5 Possible future studies 
 
   In the future, several directions can be dug into for the novel triazole-borane complexes: 
1) Reactions will be designed for the mechanistic study of  the triazole-borane reductions; 
2) Asymmetric reductive amination by chiral triazole-boranes;  
3) Design and synthesis of water soluble triazole-boranes for biological applications. 
 
4. Conclusion 
 
    In conclusion, the triazole-boranes were successfully prepared and applied as 
reductants in ketone/aldehyde reductive amination. Compared with literature reported 
systems, the triazole-boranes showed clear advantages regarding efficiency, proton and 
thermal stability, which made them new practical reagents for related chemical and 
biological research. Detailed studies regarding reaction mechanism (borane dissociation 
process) and application of this new reagent for other important transformations are 
currently under investigation in our group. 
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Part III 
Experimental Section 
 
General Methods and Materials: 
 
Unless otherwise noted, all commercial reagents and solvents were obtained from the 
commercial provider and used without further purification. Air and/or moisture-sensitive 
reactions were carried out under an atmosphere of nitrogen using oven/flame-dried glassware 
and standard syringe/septa techniques. 
1
H-NMR and 
13
C-NMR spectra were recorded on Joel 
270 MHz and Varian 600 MHz spectrometers. Chemical shifts were reported relative to internal 
tetramethysilane (? 0.00 ppm) or CDCl3 (? 7.26 ppm) for 1H and CDCl3 (? 77.0 ppm) for 13C or 
CD3OD (? 4.87, 3.31 ppm) for 1H and CD3OD (? 49.1 ppm) for 13C. Melting points were 
measured on a Mel-Temp 1001D apparatus and uncorrected. HRMS were recorded on LTQ-
FTUHRA spectrometer. Flash column chromatography was performed on 230-430 mesh silica 
gel. Analytical thin layer chromatography was performed with precoated glass baked plates 
(250μ) and visualized by fluorescence and by charring after treatment with potassium 
permanganate stain. 
 
The nitroalkene starting materials 1a-1e were prepared according to reported procedures: 1) 
Ohta, H.; Kobayashi, N.; Ozaki, K. J. Org. Chem. 1989, 54, 1802-1804. 2) Matin, N. J. A.; 
Ozores, L.; List, B. J. Am. Chem. Soc. 2007, 129, 8976-8977.  Nitroalkene 1f-1h were prepared 
according to reported procedure: 3) Jang, Y. J.; Lin, W. W.; Shih, Y. K.; Liu, J. T.; Hwang, M. H.; 
Yao, C. F. Tetrahedron, 2003, 59, 4979–4992. Vinyl esters 4b-4d were prepared according to 
reported procedures: Bedoukian, P. Z. J. Am. Chem. Soc. 1944, 66, 1325-1327. 
Triazoles 6a-6h were prepared according to the literature: Liu, Y.; Yan, W.; Chen, Y.; Petersen, 
J. L.; Shi, X. Org. Lett. 2008, 10, 5389--5392. 
 
 
General Procedure for synthesis of Isoxazoline-N-Oxide :  
  
+
OAc 20 % Pro. 1 eq. NaOAc
DMSO, rt, 12h
ON
O
Ph Ph
NO2
Ph
1a                                  4a                                                                                3a  
 
To a 25 ml vial was added L-Proline (23mg, 0.2 mmol) and Sodium acetate (82 mg, 1 mmol) in 
10 ml DMSO, then vinyl ester 4a (172 mg, 2.0 mmol) and nitroalkene 1a (163 mg, 1.0 mmol) 
were added sequent. The resulting reaction mixture was stirred at room temperature and 
monitored by TLC. After the reaction completed, the resulting brown solution was diluted with 
ethyl acetate, and washed with water (30 mlx3). The aqueous phase was extracted with ethyl 
acetate and the combined organic phase was washed with water and brine, then dried over 
Na2SO4. After remove solvent by evaporator, the residue product was purified by flash silica gel 
chromatography gave the Isoxazoline-N-Oxide 3a as colorless oil in 88% yield. 
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General Procedure for transformation Isoxazoline-N-oxide to Isoxazoline 
 
ON
O
Ph Ph
P(OMe)3
reflux
ON
Ph Ph
3a 5a  
 
The Isoxazoline-N-oxide 3a ( 305 mg, 1 mmol) was dissolved in 8 ml trimethyl phosphite in a 
flask equipped with a condenser. The solution was well degassed and heated to reflux under N2. 
After 12 h the  TLC analysis (hexane / ethyl acetate = 7/1) revealed that the starting material was 
consumed. The reaction was cooled to 0 
o
C then diethyl ether was added and the solution was 
washed with 1 N HCl (3x10 ml), water (10 ml). The organic layer was dried over Na2SO4 and 
concentrated in vacuo. The crude product was purified by flash silica gel chromatography gave 
the Isoxazoline 5a as colorless oil in 81% yield. 
 
Compound 5b was synthesized by the same procedure as above. 
 
General Procedure for transformation Isoxazoline-N-oxide to Isoxazole 
 
ON
O
Ph Ph
microwave 150W, 160 oC, 15min ON
Ph Ph
3a 5c
DMF
 
 
The starting material 3a (100 mg, 0.34 mmol) was dissolved in 2 ml DMF. Then the sealed 
reaction tube was heated to 160
 o
C by microwave (150 W) for 15 min. After cooled to room 
temperature, the solution was diluted with ethyl acetate (30 ml) and washed with water and 
brine. The organic layer was dried over Na2SO4 and concentrated in vacuo. The crude product 
was purified by flash silica gel chromatography gave the Isoxazole 5c as colorless oil in 71% 
yield. 
 
General Procedure for transformation 5b to 5d 
 
ON
CH3
1. LiAlH4, THF      
 2.H3O+
5b 5d
CH3
OHHN
Ac
3. Ac2O, Et3N
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LiAlH4 (222 mg, 6 mmol) was suspended in 6 ml THF under N2. Then Isoxazoline 5b (245 mg, 1 
mmol) in 5 ml THF was added dropwise at 0 
o
C. After 2 h the reaction was allowed to warm to 
room temperature and keep stirring for another 12 h. TLC analysis (hexane / ethyl acetate = 5/1 ) 
revealed that the starting material was consumed. Then 5.0 ml of 6N HCl was added dropwise at 
-5
 o
C and the mixture was extracted several times with ethyl acetate, the organic layer was 
washed with water and brine, dried over Na2SO4 and concentrated in vacuo. The crude product 
was used directly for the next step.  
The previous product was dissolved in 5 ml Et3N, then Ac2O (0.5 ml, 5 mmol) was added 
dropwise at room temperature. After 12 h the reaction mixture was concentrated in vacuo, 
diluted with CH2Cl2 and washed with saturated NaHCO3, the organic layer was washed with 
water and brine, dried over Na2SO4. After remove solvent by evaporator, the residue product was 
purified by flash silica gel chromatography gave the N-1,3-dicyclohexenyl-3-hydroxy-2-
methylpropyl) acetamide 5d as colorless oil in 65% yield 
 
Procedure for deuterium study and 1H NMR spectrum 
 
 
ON
O
Ph PhMe
20 % Pro. 1 eq. NaOAc
DMSO / D2O = 3 / 1, rt, 12h
   3a
No D-H exchange
 
 
 
ON
O
Ph PhCD3
D
H(D)
(D)H
H(D)
H(D)+
OAc 20 % Pro. 1 eq. NaOAc
DMSO / D2O = 3 / 1, rt, 12h
NO2
Ph
1a                           4a                                                                                               3a  
 
To a 25 ml vial was added L-Proline (23mg, 0.2 mmol) and Sodium acetate (82 mg, 1 mmol) in 
the mixture of 7.5 ml DMSO and 2.5 ml D2O, then vinyl ester 4a (172 mg, 2.0 mmol) and 
nitroalkene 1a (163 mg, 1.0 mmol) were added sequent. The resulting reaction mixture was 
stirred at room temperature and monitored by TLC. After the staring material consumed, the 
reaction was worked up using the same procedure described above for the synthesis of 
isoxazoline-N-oxide, gave the deuterated product in 35% yield. 
 
The compared spectrums are listed blow. 
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Representative Procedure for synthesis of 1,2,3-Triazole-Borane complexes: 
 
N
N
N
CH3
N
N
N
CH3
BH3
BH3-THF
THF, rt
N2
6b 7a  
ON
O
Ph PhCD3
D
H(D)
(D)H
H(D)
H(D)
ON
O
Ph PhMe
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The N-1 methyl benzotriazole 6b (1.331 g, 10 mmol, 1 equiv) was dissolved in dry THF (10 mL, 
1.0 M) in a 50ml round bottom flask under N2 atmosphere. To this solution was added BH3-THF 
(11 mL, 1.0 M in THF, 1.1 equiv) drop wise by a syringe. The resulting solution was stirred at 
room temperature and checked by TLC. A white precipitate was formed in about 10 min. After 
the completion of the reaction, 7a (1.470 g, 10 mmol, yield: 99%) was obtained by filtration as 
white solid.  
 
N
N
N
Ph
N
N
N
Ph
BH3
BH3-THF
THF, rt
N2
6d 7b  
 
The N-1 phenyl benzotriazole 6d (1.952 g, 10 mmol, 1 equiv) was dissolved in dry THF (10 mL, 
1.0 M) in a 50 mL round bottom flask under N2 atmosphere. To this solution was added BH3-
THF (11ml, 1.0 M in THF, 1.1 equiv) drop wise by a syringe. The resulting solution was stirred 
at room temperature and checked by TLC. When the reaction was completed, the resulting 
solution was concentrated and then added dry hexanes (10 mL), A white precipitate was formed 
immediately. 7b (2.090 g, 10 mmol, yield: 99%) was obtained by filtration as white solid.  
 
Representative Procedure for Reductive Amination of Aldehydes 
 
H
O
7b
DCE, rt
Cl
NH2
Cl
N
H
8a 9a 10a  
 
The 4-chlorobenzaldehyde 8a (147.6 mg, 1.05 mmol, 1.05 equiv) and aniline 9a (93.13 mg, 1 
mmol, 1 equiv) were dissolved in DCE (4 mL, 0.25 M). To this solution was added 7b (83.6 mg, 
0.4 mmol, 0.4 equiv) at room temperature. The resulting mixture was then stirred and checked by 
TLC. After the completion of the reaction, the mixture was quenched with water (10 mL), 
concentrated and extracted with ethyl acetate (10 mL x 3). The combined organic layer was 
washed with brine and dried over with anhydrous Na2SO4. The solvent was removed under 
reduced pressure to give a residue. The residue was purified by flash silica gel chromatography to 
obtain 10a (218.0 mg, 1 mmol, yield: 99%) as colorless oil. 
 
Representative Procedure for Reductive Amination of Ketones 
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O
condition A
or condition B N
HNH211b 12b  
 
 
Condition A: The cyclohexanone 11b (127.6 mg, 1.3 mmol, 1.3 equiv), p-toluidine (107.2 mg, 1 
mmol, 1 equiv) and AcOH (18 mg, 0.3 mmol, 0.3 equiv) were dissolved in DCE (4 mL, 0.25 M). 
To this solution was added the 7a (117.6 mg, 0.8 mmol, 0.8 equiv) at room temperature. The 
resulting mixture was then stirred and checked by TLC. After the completion of the reaction, the 
mixture was quenched with water (10 mL), concentrated and extracted with ethyl acetate (10 mL 
x 3). The combined organic layer was washed with brine and dried over with anhydrous Na2SO4. 
The solvent was removed under reduced pressure to give a residue. The residue was purified by 
flash silica gel chromatography to obtain 12b (189.1 mg, 1 mmol, yield: 99%) as white solid. 
 
Condition B: The cyclohexanone 11b (127.6 mg, 1.3 mmol, 1.3 equiv), p-toluidine (107.2 mg, 1 
mmol, 1 equiv) were dissolved in DCE (4 mL, 0.25 M). To this solution was added the 7a (88.2 
mg, 0.6 mmol, 0.6 equiv) at room temperature. The resulting mixture was then stirred at 60oC and 
checked by TLC.  After the reaction was completed, the mixture was cooled down and quenched 
with water (10 mL), concentrated and extracted with ethyl acetate (10 mL x 3). The combined 
organic layer was washed with brine and dried over with anhydrous Na2SO4. The solvent was 
removed under reduced pressure to give a residue, the residue was purified by flash silica gel 
chromatography to obtain 12b (189.1 mg, 1 mmol, yield: 99%) as white solid. 
 
Representative Procedure for Reductive Amination of Amino Acid 
 
30% Na2CO3, 7a
MeOH/H2O 1:1
S NH2
COOH
S
H
N
COOH
Cl
13c 8a 14c
Cl
H
O
 
 
The methionine 13c (149.2 mg, 1 mmol, 1 equiv) and Na2CO3 (31.8 mg, 0.3 mmol, 0.3 equiv) 
were dissolved in water (3 mL). To this solution was added 4-chlorobenzaldehyde 8a (210.8 mg, 
1.5 mmol, 1.5 equiv), methanol (2 mL) and 7a (220.5 mg, 1.5 mmol, 1.5 equiv) successively at 
room temperature. The resulting mixture was then stirred and checked by TLC. After the 
completion of the reaction, the resulting mixture was filtered to remove the indissoluble solid 
(6b). The solvent of the filtered solution was removed to get a residue. The residue was then 
diluted with CH2Cl2 (5 mL) and water (5 mL). 0.1 M HCl solution was added to the solution 
until pH = 7, then a white solid was obtained by filtration of the mixture. 14c was purified by 
recrystallization (MeOH/H2O = 3:1) from the white solid as white crystal (232 mg, 0.85 mmol, 
yield: 85%). 
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Compounds Characterization: 
 
ON
O
Ph PhMe
3a  
4-Methyl-3, 5-bis(1-phenylvinyl)isoxazoline-N-oxide 3a   
Purified by flash chromatography (hexane-EtOAc, v/v = 7/1) as colorless oil (yield: 88%); 
1
H 
NMR (270 MHz, CDCl3) ? 7.42-7.30 (m, 5H), 7.28-7.20 (m, 3H), 7.06-6.98 (m, 2H), 6.24 (s, 
1H), 5.71 (s, 1H), 5.62 (s, 1H), 5.48 (s, 1H), 5.02 (d, J = 5.4 Hz, 1H), 3.21-3.12 (m, 1H), 1.03 (d, 
J = 6.7 Hz, 3H); 13C NMR (67.5 MHz, CDCl3): ? 144.9, 138.2, 137.8, 135.7, 128.8, 128.5, 
128.4, 128.2, 127.5, 127.1, 121.8, 117.5, 115.4, 82.6, 45.4, 17.7; HRMS Calculated for 
C20H19NO2 [M+H]
+
: 306.14940, Found: 306.14925. 
 
ON
O
Ph PhEt
3b  
4-Ethyl-3, 5-bis(1-phenylvinyl)isoxazoline-N-oxide 3b 
Purified by flash chromatography (hexane-EtOAc, v/v = 7/1) as colorless oil (yield: 76%); 
1
H 
NMR (270 MHz, CDCl3) ? 7.38-7.34 (m, 5H), 7.25-7.20 (m, 3H), 7.00-6.96 (m, 2H), 6.25 (d, J = 
0.73 Hz, 1H), 5.72 (d, J = 0.76 Hz, 1H), 5.63 (s, 1H), 5.44 (s, 1H), 5.11 (d, J = 2.46 Hz, 1H), 
3.04-2.99 (m, 1H), 1.46-1.35 (m, 2H), 0.75 (t, J = 7.43 Hz, 3H); 13C NMR (67.5 MHz, CDCl3): ? 
145.8, 138.3, 137.9, 135.9, 128.8, 128.4, 128.1, 127.5, 127.3, 121.7, 116.3, 115.3, 80.0, 51.3, 
24.9, 9.97; HRMS Calculated for C21H21NO2 [M+H]
+
: 320.16503, Found: 320.16480. 
 
ON
O
Ph PhnPr
3c  
4-Propyl-3, 5-bis(1-phenylvinyl)isoxazoline-N-oxide 3c 
Purified by flash chromatography (hexane-EtOAc, v/v = 7/1) as colorless oil (yield: 71%); 
1
H 
NMR (270 MHz, CDCl3) ? 7.41-7.28 (m, 5H), 7.27-7.18 (m, 3H), 6.99-6.95 (m, 2H), 6.27 (d, J = 
0.76 Hz, 1H), 5.71 (d, J = 0.73 Hz, 1H), 5.63 (s, 1H), 5.43 (s, 1H), 5.09 (d, J = 2.48 Hz, 1H), 
3.06-3.01 (m, 1H), 1.50-0.81 (m, 4H), 0.56 (t, J = 7.18 Hz, 3H); 13C NMR (67.5 MHz, CDCl3): ? 
145.6, 138.1, 137.7, 135.7, 128.6, 128.2, 128.0, 127.3, 127.1, 121.5, 116.5, 115.1, 80.2, 49.5, 
33.7, 18.6, 13.2; HRMS Calculated for C22H23NO2 [M+H]
+
: 334.18070, Found: 334.18049. 
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ON
O
Ph PhCH2Bn
3d  
4-(Phenylethyl)-3, 5-bis(1-phenylvinyl)isoxazoline-N-oxide 3d 
Purified by flash chromatography (hexane-EtOAc, v/v = 7/1) as colorless oil (yield: 65%); 
1
H 
NMR (600 MHz, CDCl3) ? 7.39-7.34 (m, 5H), 7.26-7.19 (m, 4H), 7.13-7.11 (m, 2H), 6.94-6.92 
(m, 2H), 6.75-6.73 (m, 2H), 6.25 (s, 1H), 5.71 (s, 1H), 5.62 (s, 1H), 5.48 (s, 1H), 5.02(d, J = 5.4 
Hz, 1H), 3.21-3.12 (m, 1H), 2.53-2.48 (m, 1H), 2.38-2.32 (m, 1H), 1.82-1.75 (m, 1H), 1.71-1.65 
(m, 1H); 
13
C NMR (150 MHz, CDCl3): ? 145.8, 140.0, 138.2, 137.9, 135.7, 128.8, 128.37, 
128.35, 128.1, 128.0, 127.4, 127.3, 126.0, 121.7, 116.2, 115.6, 80.5, 49.3, 33.2, 31.6; HRMS 
Calculated for C27H25NO2 [M+H]
+
: 396.19635, Found: 396.19625. 
 
ON
O
Me
3e
Me Me
 
4-Methyl-3, 5-bis(1-p-tolylvinyl)isoxazoline-N-oxide 3e 
Purified by flash chromatography (hexane-EtOAc, v/v = 7/1) as colorless oil (yield: 83%); 
1
H 
NMR (270 MHz, CDCl3) ? 7.29-7.25 (m, 2H), 7.19-7.16 (m, 2H), 7.07-7.04 (m, 2H), 6.95-6.92 
(m, 2H), 6.18 (d, J = 0.73 Hz, 1H), 5.69 (d, J = 0.76 Hz, 1H), 5.58 (s, 1H), 5.44 (s, 1H), 5.01(d, J 
= 3.7 Hz, 1H), 3.23-3.13 (m, 1H), 2.35 (s, 3H), 2.31 (s, 3H), 1.03 (d, J = 6.91 Hz, 3H); 13C NMR 
(67.5 MHz, CDCl3): ? 144.7, 138.3, 138.1, 135.5, 135.3, 134.8, 129.5, 129.2, 127.4, 126.9, 
121.3, 117.8, 114.4, 82.4, 45.6, 21.2, 17.7; HRMS Calculated for C22H23NO2 [M+H]
+
: 
334.18016, Found: 334.17992. 
 
ON
O
CH2Bn
3f
Me Me
 
4-(Phenylethyl)-3, 5-bis(1-p-tolylvinyl)isoxazoline-N-oxide 3f 
Purified by flash chromatography (hexane-EtOAc, v/v = 6/1) as colorless oil (yield: 66%); 
1
H 
NMR (270 MHz, CDCl3) ? 7.25-7.17 (m, 4H), 7.11-7.07 (m, 3H), 7.00-6.97 (m, 2H), 6.83-6.79 
(m, 2H), 6.75-6.69 (m, 2H), 6.20 (d, J = 0.76 Hz, 1H), 5.67 (d, J = 0.73 Hz, 1H), 5.59 (s, 1H), 
5.39 (s, 1H), 5.14 (d, J = 2.21 Hz, 1H), 3.11-3.07 (m, 1H), 2.55-2.45 (m, 1H), 2.36 (s, 3H), 2.31 
(s, 3H), 1.82-1.59 (m, 2H); 
13
C NMR (67.5 MHz, CDCl3): ? 145.7, 140.2, 138.3, 138.0, 135.6, 
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135.4, 135.0, 129.5, 129.1, 128.4, 128.2, 127.4, 127.3, 125.9, 121.3, 116.5, 114.8, 80.5, 49.5, 
33.3, 31.7, 21.3; HRMS Calculated for C29H29NO2 [M+H]
+
: 424.22711, Found: 424.22673. 
 
ON
O
Me
3g
Cl Cl
 
4-Methyl-3, 5-bis(1-p-chlorophenylvinyl)isoxazoline-N-oxide 3g 
Purified by flash chromatography (hexane-EtOAc, v/v = 6/1) as colorless oil (yield: 77%); 
1
H 
NMR (270 MHz, CDCl3) ? 7.38-7.30 (m, 3H), 7.25-7.22 (m, 3H), 6.97-6.93 (d, J = 8.7 Hz 2H), 
6.15 (s, 1H), 5.69 (s, 1H), 5.61 (s, 1H), 5.46 (s, 1H), 4.98 (d, J = 4.13 Hz, 1H), 3.16-3.07 (m, 
1H), 1.06 (d, J = 6.94 Hz, 3H); 13C NMR (67.5 MHz, CDCl3): ? 143.7, 136.3, 136.0, 134.7, 
134.5, 134.3, 129.1, 128.8, 128.7, 128.5, 122.3, 117.1, 116.4, 82.6, 45.3, 17.7; HRMS Calculated 
for C20H17Cl2NO2 [M+H]
+
: 374.07146 Found: 374.07137 
 
ON
O
Et
3h
Cl Cl
 
4-Ethyl-3, 5-bis(1-p-chlorophenylvinyl)isoxazoline-N-oxide 3h 
Purified by flash chromatography (hexane-EtOAc, v/v = 6/1) as colorless oil (yield: 58%); 
1
H 
NMR (600 MHz, CDCl3) ? 7.36 (d, J = 8.4 Hz, 2H), 7.31 (d, J = 8.4 Hz, 2H), 7.22 (d, J = 9.0 
Hz, 2H), 6.90 (d, J = 8.4 Hz, 2H), 6.17 (s, 1H), 5.69 (s, 1H), 5.61 (s, 1H), 5.42 (s, 1H), 5.07 (d, J 
= 3.0 Hz, 1H), 2.98-2.95 (m, 1H), 1.46-1.43 (m, 2H), 0.79 (t, J = 7.2 Hz, 3H); 13C NMR (150 
MHz, CDCl3): ? 145.0, 136.7, 136.3, 135.1, 134.7, 134.5, 129.2, 128.87, 128.85, 128.8, 122.3, 
116.4, 115.8, 81.5, 58.0, 25.2, 11.1; HRMS Calculated for C21H19Cl2NO2 [M+H]
+
: 388.08656, 
Found: 388.08666. 
ON
O
Me
3i  
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4-Methyl-3, 5-bis(1-(2-naphthyl)vinyl)isoxazoline-N-oxide 3i 
Purified by flash chromatography (hexane-EtOAc, v/v = 5/1) as colorless oil (yield: 75%); 
1
H 
NMR (600 MHz, CDCl3) ? 7.87-7.83 (m, 4H), 7.22 (d, J = 7.8 Hz, 1H), 7.61 (d, J = 7.4 Hz, 1H), 
7.58 (dd, J = 1.8 Hz, J = 7.4 Hz, 1H), 7.52-7.48 (m, 3H), 7.43-7.36 (m, 3H), 7.10 (dd, J = 1.8 Hz, 
J = 7.4 Hz, 1H), 6.32 (s, 1H), 5.82 (s, 1H), 5.75 (s, 1H), 5.64 (s, 1H), 5.16 (d, J = 3.6 Hz, 1H), 
3,30-3,28 (m, 1H), 1.07 (d, J = 6.6 Hz, 1H); 13C NMR (150 MHz, CDCl3): ? 144.9, 135.5, 135.4, 
135.1, 133.2, 133.0, 132.9, 132.7, 128.5, 128.1, 128.0, 127.9, 127.6, 126.5, 126.44, 126.41, 126.3, 
126.2, 125.9, 125.1, 124.9, 122.0, 117.5, 115.9, 82.6, 45.4, 17.6; HRMS Calculated for 
C28H23NO2 [M+H]
+
: 406.18016, Found: 406.18031. 
 
ON
O
3j
Ph
 
4-(Phenylethyl)-3, 5-bis(1-(2-naphthyl)vinyl)isoxazoline-N-oxide 3j 
Purified by flash chromatography (hexane-EtOAc, v/v = 5/1) as colorless oil (yield: 61%); 
1
H 
NMR (600 MHz, CDCl3) ? 7.87-7.81 (m, 3H), 7.73 (s, 1H), 7.70 (d, J = 7.8 Hz, 1H), 7.54-7.47 
(m, 4H), 7.42-7.39 (m, 1H), 7.37-7.33 (m, 2H), 7.21 (s, 1H), 6.92 (dd, J = 1.8 Hz, J = 7.4 Hz, 
1H), 6.82 (t, J = 7.8 Hz, 1H), 6.70 (t, J = 7.8 Hz, 1H), 6.45 (d, J = 7.2 Hz, 1H), 6.37 (s, 1H), 5.77 
(s, 1H), 5.73 (s, 1H), 5.55 (s, 1H), 5.26 (d, J = 3.0 Hz, 1H), 3.14-3.11 (m, 1H), 2.51-2.46 (m, 1H), 
2.31-2.26 (m, 1H), 1.84-1.76 (m, 1H), 1.69-1.63 (m, 1H); 
13
C NMR (150 MHz, CDCl3): ? 145.8, 
139.3, 135.5, 135.4, 135.3, 133.2, 133.0, 132.8, 133.7, 128.5, 128.1, 128.0, 127.6, 127. 4, 126.6, 
126.5, 126.4, 126.2, 125.7, 125.18, 125.16, 122.06, 116.37, 80.7, 48.9, 32.9, 31.3; HRMS 
Calculated for C35H29NO2 [M+H]
+
: 496.22711, Found: 496.22691. 
 
ON
O
Ph PhMe
3k  
4-Methyl-3, 5-bis((E)-1-phenylprop-1-enyl)isoxazoline-N-oxide 3k 
Purified by flash chromatography (hexane-EtOAc, v/v = 7/1) as colorless oil (yield: 75%), 
colorless solid formed several days later. m.p. 152-154 
o
C; 
1
H NMR (600 MHz, CDCl3) ? 7.40-
7.37 (m, 2H), 7.34-7.31 (m, 1H), 7.25-7.22 (m, 3H), 7.20-7.18 (m, 2H), 6.99 (q, J = 7.2 Hz, 1H), 
6.72-6.71 (m, 2H), 5.95-5.91 (q, J = 6.6 Hz), 4.63 (d, J = 3.6 Hz, 1H), 2.83-2.81 (m, 1H), 1.63 (t, 
J = 7.2 Hz, 3H), 1.57 (t, J = 7.2 Hz, 3H), 0.89 (d, J = 6.6 Hz, 3H); 13C NMR (150 MHz, CDCl3): 
? 138.3, 136.3, 136.2, 132.4, 129.59, 129.56, 128.9, 128.7, 128.4, 127.8, 127.6, 127.5, 118.9, 
85.9, 44.7, 18.0, 15.4,14.6; HRMS Calculated for C22H23NO2 [M+H]
+
: 334.18016, Found: 
334.18013. 
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ON
O
Me
3l  
4-Methyl-3, 5-dicyclohexenylisoxazoline-N-oxide 3l 
Purified by flash chromatography (hexane-EtOAc, v/v 7/1) as pale yellow solid (yield 87%), 
m.p. 126-128 
o
C;
 1
H NMR (600 MHz, CDCl3): ? 6.43-6.41 (m, 1H), 5.75 (s, 1H), 4.66 (d, J = 3.6 
Hz, 1H), 3.28-3.26 (m, 1H), 2.54-2.50 (m, 1H), 2.28-2.19 (m, 3H), 2.10-2.02 (m, 3H), 1.92-1.88 
(m, 1H), 1.75-1.52 (m, 8H), 1.31 (d, J = 6.6 Hz, 3H); 13C NMR (150 MHz, CDCl3): ? 134.4, 
131.7, 125.8, 125.1, 120.1, 85.5, 43.3, 25.8, 25.5, 24.8, 22.8, 22.3, 22.12, 22.1, 21.4, 18.2; 
HRMS Calculated for C16H23NO2 [M+H]
+
: 262.18070, Found: 262.18030. 
 
ON
O
Et
3m  
4-Ethyl-3, 5-dicyclohexenylisoxazoline-N-oxide 3m 
Purified by flash chromatography (hexane-EtOAc, v/v 7/1) as pale yellow solid (yield 80%), 
m.p. 115-117 
o
C;
 1
H NMR (270 MHz, CDCl3): ? 6.41-6.40 (m, 1H), 5.75 (s, 1H), 4.45 (d, J = 2.5 
Hz, 1H), 3.07-3.05 (m, 1H), 2.51-2.44 (m, 1H), 2.27-2.15 (m, 3H), 2.08-1.95 (m, 3H), 1.91-1.77 
(m, 1H), 1.71-1.48 (m, 10H), 0.95 (t, J = 7.4 Hz, 3H); 13C NMR (67.5 MHz, CDCl3): ? 135.4, 
131.7, 125.2, 125.0, 124.9, 119.0, 82.6, 50.0, 26.0, 25.6, 25.1, 24.8, 22.8, 22.2, 21.5, 10.4; 
HRMS Calculated for C17H25NO2 [M+H]
+
: 276.19635, Found: 276.19597. 
 
ON
O
nPr
3n  
4-Propyl-3, 5-dicyclohexenylisoxazoline-N-oxide 3n 
Purified by flash chromatography (hexane-EtOAc, v/v 7/1) as pale yellow solid (yield 74%), 
m.p. 119-121 
o
C;
 1
H NMR (600 MHz, CDCl3): ? 6.44-6.42 (m, 1H), 5.77 (s, 1H), 4.46 (s, 1H), 
3.13-3.10 (m, 1H), 2.54-2.46 (m, 1H), 2.28-2.16 (m, 3H), 2.08-1.95 (m, 3H), 1.90-1.84 (m, 1H), 
1.74-1.50 (m, 10H), 1.48-1.32 (m, 2H), 0.94 (t, J = 7.2 Hz, 3H); 13C NMR (67.5 MHz, CDCl3): ? 
135.4, 131.8, 125.2, 124.9, 119.2, 83.1, 48.5, 34.2, 26.0, 25.6, 24.8, 22.8, 22.4, 22.2, 21.5, 19.4, 
13.9; HRMS Calculated for C18H27NO2 [M+H]
+
: 290.21200, Found: 290.21166. 
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ON
O
CH2Bn
3o  
4--(Phenylethyl)-3, 5-dicyclohexenylisoxazoline-N-oxide 3o 
Purified by flash chromatography (hexane-EtOAc, v/v 7/1) as pale yellow solid (yield 70%), 
m.p. 123-125 
o
C;
 1
H NMR (270 MHz, CDCl3): ? 7.35-7.10 (m, 5H), 6.27 (s, 1H), 5.78 (s, 1H), 
4.56 (s, 1H), 3.17-3.10 (m, 1H), 2.84-2.56 (m, 2H), 2.51-2.38 (m, 1H), 2.24-1.80 (m, 9H), 1.72-
1.48 (m, 8H); 
13
C NMR (67.5 MHz, CDCl3): ? 140.6, 135.2, 131.9, 128.6, 128.4, 126.3, 125.6, 
125.1, 119.0, 83.1, 77.5, 77.1, 76.6, 47.8, 32.2, 26.0, 25.5, 24.9, 22.8, 22.4, 22.2; HRMS 
Calculated for C23H29NO2 [M+H]
+
: 352.22765, Found: 352.22747 
 
ON
O
Me
3p  
4-Methyl-3, 5-dicyclopentenylisoxazoline-N-oxide 3P 
Purified by flash chromatography (hexane-EtOAc, v/v 7/1) as pale yellow solid (yield 72%), 
m.p.48-50 
o
C;
 1
H NMR (270 MHz, CDCl3): ? 6.44 (s, 1H), 5.75 (s, 1H), 4.66 (d, J = 3.7 Hz, 1H), 
3.28-3.15 (m, 1H), 2.84-2.67 (m, 1H), 2.66-2.52 (m, 1H), 2.45-2.42 (m, 2H), 2.35-2.20 (m, 4H), 
1.98-1.79 (m, 4H), 1.32 (d, J = 6.9 Hz, 3H); 13C NMR (67.5 MHz, CDCl3):? 140.5, 134.7, 134.6, 
129.9, 129.3, 117.6, 81.1, 43.7, 33.3, 32.7, 32.2, 30.6, 23.2, 17.8; HRMS Calculated for 
C14H19NO2 [M+H]
+
: 234.14940, Found: 234.14951. 
 
ON
O
Et
3q  
4-Ethyl-3, 5-dicyclopentenylisoxazoline-N-oxide 3q 
Purified by flash chromatography (hexane-EtOAc, v/v 7/1) as colerless oil (yield 65%);
 1
H NMR 
(270 MHz, CDCl3): ? 6.48-6.44 (m, 1H), 5.77 (s, 1H), 4.82 (s, 1H), 3.07-3.05 (m, 1H), 2.83-2.58 
(m, 1H), 2.53-2.45 (m, 2H), 2.39-2.28 (m, 4H), 1.99-1.87 (m, 5H), 1.78-1.68 (m, 2H), 0.99 (t, J 
= 7.4 Hz, 3H); 
13
C NMR (67.5 MHz, CDCl3): ? 141.5, 134.5, 130.0, 128.5, 116.2, 79.0, 50.3, 
33.3, 32.7, 32.2, 30.6, 24.6, 23.2, 10.5; HRMS Calculated for C15H21NO2 [M+H]
+
: 248.16451, 
Found: 248.16442. 
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ON
O
Me
3r
Me Me
 
4-Methyl-3, 5-di(prop-1-en-2-yl)isoxazoline-N-oxide 3r 
Purified by flash chromatography (hexane-EtOAc, v/v = 8/1) as colorless oil (yield: 55%); 
1
H 
NMR (270 MHz, CDCl3) ? 5.55 (s, 1H), 5.29 (s, 1H), 5.10 (s, 1H), 4.94 (s, 1H), 4.45 (d, J = 3.94 
Hz, 1H), 3.33-3.22 (m, 1H), 2.09 (s, 3H), 1.77 (s, 3H), 1.36 (d, J = 6.94 Hz 3H); 13C NMR (67.5 
MHz, CDCl3): ? 141.1, 131.0, 119.5, 118.9, 113.5, 84.2, 43.9, 20.5, 18.2, 16.9; HRMS 
Calculated for C10H15NO2 [M+H]
+
: 182.11756, Found: 182.11743. 
 
ON
Ph PhMe
5a  
4-Methyl-3, 5-bis(1-phenylvinyl)isoxazoline 5a 
Purified by flash chromatography (hexane-EtOAc, v/v = 10/1) as pale yellow oil (yield: 81%); 
1
H NMR (270 MHz, CDCl3) ? 7.44-7.29 (m, 10H), 5.56 (s, 1H), 5.51 (s, 1H), 5.46 (s, 1H), 5.41 
(s, 1H), 5.21 (d, J = 4.97 Hz, 1H), 3.31-3.21 (m, 1H), 1.28 (d, J = 7.18 Hz, 3H); 13C NMR (67.5 
MHz, CDCl3): ? 161.7, 145.7, 139.1, 138.3, 138.2, 128.7, 128.3, 128.2, 128.1, 127.1, 120.3, 
114.2, 89.75, 48.5, 18.2; HRMS Calculated for C20H19NO [M+H]
+
: 290.15449, Found: 
290.15430. 
 
ON
Me
5b  
4-Methyl-3, 5-dicyclohexenylisoxazoline 5b 
Purified by flash chromatography (hexane-EtOAc, v/v = 10/1) as pale yellow solid (yield: 90%), 
m.p.74-76 
o
C;
 
 
1
H NMR (600 MHz, CDCl3) ? 6.04-6.03 (m, 1H), 5.67 (s, 1H), 4.44 (d, J = 4.8 
Hz, 1H), 3.21-3.18 (m, 1H), 2.45-2.41 (m, 1H), 2.28-2.16 (m, 3H), 2.03-1.96 (m, 3H), 1.80-1.77 
(m, 1H), 1.69-1.49 (m, 8H), 1.25 (d, J = 7.2 Hz, 3H); 13C NMR(150 MHz, CDCl3): ? 161.8, 
136.0, 131.2, 128.7, 124.3, 92.7, 45.4, 25.8, 25.0, 24.9, 22.9, 22.28, 22.27, 22.1, 21.9, 19.3; 
HRMS Calculated for C16H23NO [M+H]
+
: 246.18524, Found: 246.18519. 
 
ON
Me
5c
Ph Ph
 
4-Methyl-3, 5-bis(1-phenylvinyl)isoxazole 5c 
Purified by flash chromatography (hexane-EtOAc, v/v = 10/1) as pale yellow oil (yield: 71%); 
1
H NMR (270 MHz, CDCl3) ? 7.45-7.23 (m, 10H), 5.86 (s, 1H), 5.78 (s, 1H), 5.76 (s, 1H), 5.66 
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(s, 1H), 1.46 (s, 3H); 
13
C NMR (67.5 MHz, CDCl3): ? 165.4, 164.1, 138.1, 137.8, 137.4, 128.63, 
128.61, 128.5, 128.4, 127.6, 126.9, 119.8, 119.3, 111.6, 8.78; HRMS Calculated for C20H17NO 
[M+H]
+
: 288.13884, Found: 288.13865. 
 
5d
Me
OHAcHN
 
N-1, 3-dicyclohexenyl-3-hydroxy-2-methylpropyl)acetamide 5d 
Purified by flash chromatography (hexane-EtOAc, v/v = 2/1) as colorless oil (yield: 65%); 
1
H 
NMR (600 MHz, CDCl3) ? 5.67 (s, 1H), 5.44 (d, J = 9.6 Hz, 1H), 3.91 (t, J = 9.6 Hz, 1H), 3.77 
(d, J = 9.6 Hz, 1H), 2.10-1.97 (m, 2H), 1.83-1.74 (m, 1H), 1.65-1.41 (m, 11H), 1.25-1.11 (m, 
2H), 0.91 (d, J = 6.6 Hz, 3H); 13C NMR (67.5 MHz, CDCl3): ? 170.0, 135.9, 126.0, 86.8, 80.4, 
64.4, 42.4, 36.7, 33.3, 25.7, 25.3, 23.7, 23.0, 22.8, 22.7, 21.8, 14.1; HRMS Calculated for 
C18H29NO2 [M+H]
+
: 292.22711, Found: 292.22695. 
 
N
N
N
BH3
CH3
7a  
1-methyl benzotriazole borane (7a): m.p. 187.2-188.9 oC. 1H NMR (600 MHz, CDCl3): ? 
8.17-8.15 (m, 1H), 7.68-7.64 (m, 2H), 7.63-7.58 (m, 1H), 4.37 (s, 3H), 2.73-2.54 (br m, 3H). 13C 
NMR (150 MHz, CDCl3): ? 139.7, 134.1, 129.3, 127.3, 118.0, 110.2, 35.7. HRMS Calculated 
for C7H11BN3 [M+H]+: 147.10769, Found: 147.10763. 
 
N
N
N
BH3
Ph
7b  
1-phenyl benzotriazole borane (7b): m.p. 91.9-92.6 oC. 1H NMR (600 MHz, CDCl3): ? 8.31 
(d, J = 8.4 Hz, 1H), 7.81-7.77 (m, 3H), 7.73-7.70 (m, 1H), 7.69-7.66 (m, 3H), 7.64-7.62 (m, 1H), 
2.88-2.65 (br m, 3H). 13C NMR (150 MHz, CDCl3): ? 140.3, 135.3, 133.2, 130.5, 130.2, 127.6, 
123.6, 118.9, 118.7, 111.3. HRMS Calculated for C12H13BN3 [M+H]+: 209.04728, Found: 
209.04723. 
 
Cl
N
H
10a  
N-(4-chlorobenzyl)benzenamine (10a). 10a was purified by flash silica gel chromatography 
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(Hexane-EtOAc, v/v = 30:1) as colorless oil, yield: 99%. m.p. 110.1-112.3 oC. 1H NMR (600 
MHz, CDCl3): ? 7.36-7.32 (m, 4H), 7.24-7.21 (m, 2H), 6.80-6.77 (m, 1H), 6.66-6.64 (m, 2H), 
4.35 (s, 2H), 4.09 (br, 1H). 13C NMR (150 MHz, CDCl3): ? 147.8, 138.0, 132.8, 129.2, 128.7, 
128.6, 117.7, 112.8, 47.5. HRMS Calculated for C13H13ClN [M+H]
+: 218.07310, Found: 
218.07318. 
 
MeO
N
H
10b  
N-(4-methoxybenzyl)benzenamine (10b). 10b was purified by flash silica gel chromatography 
(Hexane-EtOAc, v/v = 30:1) as colorless oil, yield: 99%. m.p. 112.8-114.0 oC. 1H NMR (600 
MHz, CDCl3): ? 7.33-7.31 (m, 2H), 7.22-7.20 (m, 2H), 6.93-6.91 (m, 2H), 6.77-6.74 (m, 1H), 
6.68-6.66 (m, 2H), 4.28 (s, 2H), 4.03 (br, 1H), 3.83 (s, 3H). 13C NMR (150 MHz, CDCl3): ? 
158.8, 148.1, 131.3, 129.2, 128.8, 117.5, 114.0, 112.9, 55.2, 47.8. HRMS Calculated for 
C14H16NO [M+H]
+: 214.12264, Found: 214.12278. 
 
N
H
10c  
N-benzylbenzenamine (10c). 10c was purified by flash silica gel chromatography (Hexane-
EtOAc, v/v = 50:1) as white solid, yield: 99%. m.p. 67.3-68.2 oC.1H NMR (600 MHz, CDCl3): 
? 7.43-7.39 (m, 4H), 7.35-7.32 (t, J = 7.2Hz, 1H), 7.25-7.22 (m, 2H), 6.80-6.77 (m, 1H), 6.70-
6.69 (m, 2H), 4.38 (s, 2H), 4.09 (br, 1H). 13C NMR (150 MHz, CDCl3): ? 148.1, 139.4, 129.2, 
128.6, 127.5, 127.1, 117.6, 112.8, 48.3. HRMS Calculated for C13H14N [M+H]
+: 184.11207, 
Found: 184.11220. 
 
N
H
10d
Cl
OMe
 
N-(4-chlorobenzyl)-4-methoxybenzenamine (10d). 10d was purified by flash silica gel 
chromatography (Hexane-EtOAc, v/v = 30:1) as white solid, yield: 99%. m.p. 156.1-157.8 oC.1H 
NMR (600 MHz, CDCl3): ? 7.30 (s, 4H), 6.77-6.76 (m, 2H), 6.60-6.58 (m, 2H), 4.26 (s, 2H), 
3.74 (s, 3H). 13C NMR (150 MHz, CDCl3): ? 151.4, 141.0, 139.2, 136.5, 129.0, 128.9, 115.2, 
114.6, 56.0, 48.9. HRMS Calculated for C14H15ClNO [M+H]
+: 248.08367, Found: 248.08373. 
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N
H
10e
Cl
F
 
N-(4-chlorobenzyl)-4-fluorobenzenamine (10e). 10e was purified by flash silica gel 
chromatography (Hexane-EtOAc, v/v = 30:1) as white solid, yield: 99%. m.p. 123.1-124.6 oC.1H 
NMR (600 MHz, CDCl3): ? 7.32-7.28 (m, 4H), 6.90-6.87 (m, 2H), 6.56-6.54 (m, 2H), 4.27 (s, 
2H), 4.10 (br, 1H). 13C NMR (150 MHz, CDCl3): ? 156.8, 155.3, 144.0, 137.5, 133.0, 128.7, 
115.7, 113.8, 48.3. HRMS Calculated for C13H12ClFN [M+H]
+: 236.06368, Found: 236.06398. 
 
N
H
10f
Cl
 
N-(4-chlorobenzyl)(phenyl)methanamine (10f). 10f was purified by flash silica gel 
chromatography (Hexane-EtOAc, v/v = 5:1) as white solid, yield: 95%. m.p. 121.3-122.2 oC. 1H 
NMR (600 MHz, CDCl3): ? 7.35-7.26 (m, 8H), 3.80 (s, 2H), 3.78 (s, 2H), 1.76 (br, 1H). 13C 
NMR (150 MHz, CDCl3): ? 140.0, 138.7, 132.6, 129.5, 128.5, 128.4, 128.1, 127.0, 53.0, 52.3. 
HRMS Calculated for C14H15ClN [M+H]
+: 232.08875, Found: 232.08887. 
 
N
H
10g
Cl OMe
 
N-(4-chlorobenzyl)(4-methoxyphenyl)methanamine (10g). 10g was purified by flash silica 
gel chromatography (Hexane-EtOAc, v/v = 6:1) as white solid, yield: 96%. m.p. 168.1-170.2 oC. 
1H NMR (600 MHz, CDCl3): ? 7.28-7.25 (m, 4H), 7.24-7.22 (m, 2H), 6.86-6.85 (m, 2H), 3.79 
(s, 3H), 3.76 (s, 2H), 3.75(s, 2H), 1.52 (br, 1H). 13C NMR (150 MHz, CDCl3): ? 158.6, 138.9, 
132.5, 132.2, 129.4, 129.2, 128.4, 113.8, 55.2, 52.5, 52.2. HRMS Calculated for C15H17ClNO 
[M+H]+: 262.09932, Found: 262.09947. 
 
O2N
N
H
10h
OMe
 
N-(4-nitrobenzyl)(4-methoxyphenyl)methanamine (10h). 10h was purified by flash silica gel 
chromatography (Hexane-EtOAc, v/v = 8:1) as white solid, yield: 82%. m.p. 179.0-181.2 oC. 1H 
NMR (600 MHz, CDCl3): ? 8.18-8.17 (m, 2H), 7.53-7.51 (m, 2H), 7.26-7.24 (m, 2H), 6.88-
6.87(m, 2H), 3.89 (s, 2H), 3.80 (s, 3H), 3.75(s, 2H), 1.64 (br, 1H). 13C NMR (150 MHz, 
CDCl3): ? 158.8, 148.2, 147.0, 131.9, 129.3, 128.6, 123.6, 113.9, 55.3, 52.6, 52.2. HRMS 
Calculated for C15H17N2O3 [M+H]
+: 273.12337, Found: 273.12350. 
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Cl
N
H
10i  
N-(4-chlorobenzyl)butan-1-amine (10i). 10i was purified by flash silica gel chromatography 
(Hexane-EtOAc, v/v = 3:1) as colorless oil, yield: 91%. 1H NMR (600 MHz, CDCl3): ? 7.30-
7.26 (m, 4H), 3.76 (s, 2H), 2.61 (t, J = 7.2Hz, 2H), 1.81 (br, 1H), 1.53-1.48 (m, 2H), 1.37-1.33 
(m, 2H), 0.91 (t, J = 7.2Hz, 3H). 13C NMR (150 MHz, CDCl3): ? 148.4, 147.0, 128.6, 123.6, 
53.2, 49.2, 32.2, 20.4, 13.9. HRMS Calculated for C11H17ClN [M+H]
+: 198.10440, Found: 
198.10446. 
 
Cl
N
10j  
1-(4-chlorobenzyl)pyrrolidine (10j). 10j was purified by flash silica gel chromatography 
(Hexane-EtOAc, v/v = 3:1) as yellow oil, yield: 95%. 1H NMR (600 MHz, CDCl3): ? 7.30-7.23 
(m, 4H), 3.55 (s, 2H), 2.95 (br, 1H), 2.47-2.45 (m, 4H), 1.77-1.74 (m, 4H). 13C NMR (150 
MHz, CDCl3): ? 139.6, 137.7, 130.2, 128.3, 59.9, 54.0, 23.4. HRMS Calculated for C11H15ClN 
[M+H]+: 196.08875, Found: 196.08874. 
 
Cl
N
10k  
N-(4-chlorobenzyl)-N-methylbenzenamine (10k). 10k was purified by flash silica gel 
chromatography (Hexane-EtOAc, v/v = 30:1) as yellow oil, yield: 99%. 1H NMR (600 MHz, 
CDCl3): 7.30-7.28 (m, 2H), 7.25-7.22 (m, 2H), 7.18-7.17 (m, 2H), 6.75-6.74 (m, 3H), 4.50 (s, 
2H), 3.01 (s, 3H). 13C NMR (150 MHz, CDCl3): ? 149.5, 137.5, 132.6, 129.2, 128.7, 128.1, 
116.9, 112.5, 56.2, 38.5. HRMS Calculated for C14H15ClN [M+H]
+: 232.08875, Found: 
232.08880. 
 
N
H
10l  
N-(3-phenylpropyl)benzenamine (10l). 10l was purified by flash silica gel chromatography 
(Hexane-EtOAc, v/v = 35:1) as yellow oil, yield: 99%. 1H NMR (600 MHz, CDCl3): ? 7.19-7.17 
(m, 2H), 7.10-7.03 (m, 5H), 6.60-6.57 (m, 1H), 6.46-6.44 (m, 2H), 3.44 (b, 1H), 3.01 (t, J = 7.2 
Hz, 2H), 2.60 (t, J = 7.8 Hz, 2H), 1.84-1.79 (m, 2H). 13C NMR (150 MHz, CDCl3): ? 148.3, 
141.6, 129.1, 128.4, 128.3, 125.9, 117.1, 112.7, 43.3, 33.3, 31.0. HRMS Calculated for C15H18N 
[M+H]+: 212.14338, Found: 212.14338. 
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N
N
H
10m  
N-((pyridin-4-yl)methyl)benzenamine (10m). 10m was purified by flash silica gel 
chromatography (Hexane-EtOAc, v/v = 1:1) as yellow solid, yield: 99%. m.p. 128.1-130.2 oC.1H 
NMR (600 MHz, CDCl3): ? 8.63 (s, 1H), 8.53 (d, J = 4.8 Hz, 1H), 7.70-7.69 (m, 1H), 7.27-7.25 
(m, 1H), 7.18-7.16 (m, 2H), 6.76-6.73 (m, 1H), 6.64-6.62 (m, 2H), 4.36 (s, 2H). 13C NMR (150 
MHz, CDCl3): ? 149.0, 148.6, 147.6, 129.3, 123.5, 118.0, 112.9, 45.80. HRMS Calculated for 
C12H13N2 [M+H]
+: 185.10732, Found: 185.10743. 
 
N
H
O
10n  
N-((furan-2-yl)methyl)benzenamine (10n). 10n was purified by flash silica gel 
chromatography (Hexane-EtOAc, v/v=30:1) as yellow oil, yield: 99%. 1H NMR (600 MHz, 
CDCl3): ? 7.41 (t, J = 1.2 Hz, 1H), 7.25-7.22 (m, 2H), 6.81-6.78 (m, 1H), 6.73-6.71 (m, 2H), 
6.37-6.36 (m, 1H), 6.28-6.27 (m, 1H), 4.35 (s, 2H), 4.02 (br, 1H). 13C NMR (150 MHz, CDCl3): 
? 152.7, 147.6, 141.8, 129.2, 118.0, 113.1, 110.3, 106.9, 41.4. HRMS Calculated for C11H12NO 
[M+H]+: 174.09134, Found: 174.09147. 
 
N
H
S
10o  
N-((thiophen-2-yl)methyl)benzenamine (10o). 10o was purified by flash silica gel 
chromatography (Hexane-EtOAc, v/v = 30:1) as colorless oil, yield: 99%. 1H NMR (600 MHz, 
CDCl3): ? 7.24-7.21 (m, 3H), 7.05-7.04 (m, 1H), 7.00-6.99 (m, 1H), 6.80-6.77 (m, 1H), 6.71-
6.70 (m, 2H), 4.53 (s, 2H), 4.14 (br, 1H). 13C NMR (150 MHz, CDCl3): ? 147.5, 142.8, 129.2, 
126.8, 125.0, 124.6, 118.1, 113.2, 43.5. HRMS Calculated for C11H12NS [M+H]
+: 190.06850, 
Found: 190.06860. 
 
N
H
N
NH
10p  
N-((1H-imidazol-2-yl)methyl)benzenamine (10p). 10p was purified by flash silica gel 
chromatography (Hexane-EtOAc, v/v = 4:1) as white solid, yield: 93%. m.p. 195.0-197.2 oC 1H 
NMR (600 MHz, CDCl3): ? 7.13-7.11 (m, 2H), 6.97 (s, 2H), 6.74-6.71 (m, 1H), 6.54-6.52 (m, 
2H), 4.35 (s, 2H). 13C NMR (150 MHz, CDCl3): ? 147.5, 146.6, 129.3, 121.9, 118.4, 113.1, 
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42.3. HRMS Calculated for C10H12N3 [M+H]
+: 174.10257, Found: 174.10256. 
 
N
H
10q  
N-cinnamylbenzenamine (10q). 10q was purified by flash silica gel chromatography (Hexane-
EtOAc, v/v = 50:1) as yellow oil, yield: 95%. 1H NMR (600 MHz, CDCl3): ? 7.42-7.41 (m, 2H), 
7.37-7.34 (m, 2H), 7.29-7.22 (m, 3H), 6.80-6.77 (m, 1H), 6.73-6.71 (m, 2H), 6.66 (d, J = 15.6 
Hz, 1H), 6.37 (dt, J = 15.6 Hz; 6.0 Hz, 1H), 3.97 (dd, J = 6.0 Hz; 1.8 Hz, 2H). 13C NMR (150 
MHz, CDCl3): ? 147.9, 136.8, 131.5, 129.2, 128.5, 127.5, 127.0, 126.3, 117.6, 113.1, 46.2. 
HRMS Calculated for C15H16N [M+H]
+: 210.12773, Found: 210.12785. 
 
Cl
N
H
CH3
10r  
(S)-N-(4-chlorobenzyl)-1-phenylethanamine (10r). 10r was purified by flash silica gel 
chromatography (Hexane-EtOAc, v/v = 20:1) as colorless oil, yield: 95%. 1H NMR (600 MHz, 
CDCl3): ? 7.29-7.28 (m, 4H), 7.21-7.16 (m, 5H), 3.74 (q, J = 6.6 Hz, 1H), 3.57 (d, J = 13.2 Hz, 
1H), 3.50 (d, J = 13.2 Hz, 1H), 1.33 (d, J = 6.6 Hz, 3H). 13C NMR (150 MHz, CDCl3): ? 132.9, 
129.9, 129.7, 128.6, 128.5, 127.2, 126.8, 123.0, 57.5, 50.6, 24.1. HRMS Calculated for 
C15H17ClN [M+H]
+: 246.10440, Found: 246.10456. 
 
H
N
12a  
N-benzylcyclohexanamine (12a). 12a was purified by flash silica gel chromatography (Hexane-
EtOAc, v/v = 8:1) as yellow oil, yield: 95%. 1H NMR (600 MHz, CDCl3): ? 7.33-7.30 (m, 4H), 
7.24-7.22 (m, 1H), 3.81 (s, 2H), 2.52-2.47 (m, 1H), 1.93-1.91 (m, 2H), 1.76-1.72 (m, 2H), 1.63-
1.60 (m, 1H), 1.30-1.10 (m, 5H). 13C NMR (150 MHz, CDCl3): ? 141.3, 128.6, 128.3, 127.0, 
56.4, 33.8, 26.5, 25.2. HRMS Calculated for C13H20N [M+H]
+: 190.15903, Found: 190.15904. 
 
H
N
12b  
N-cyclohexyl-4-methylbenzenamine (12b). 12b was purified by flash silica gel 
chromatography (Hexane-EtOAc, v/v = 50:1) as white solid, yield: 99%. m.p. 62.1-64.6 oC. 1H 
NMR (600 MHz, CDCl3): ? 6.99-6.98 (m, 2H), 6.55-6.53 (m, 2H), 3.37 (br, 1H), 3.26-3.22 (m, 
1H), 2.25 (s, 3H), 2.08-2.06 (m, 2H), 1.79-1.76 (m, 2H), 1.68-1.65 (m, 1H), 1.41-1.35 (m, 2H), 
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1.27-1.21 (m, 1H), 1.18-1.12 (m, 2H). 13C NMR (150 MHz, CDCl3): ? 145.4, 130.0, 126.3, 
113.7, 52.3, 33.8, 26.2, 25.3, 20.6. HRMS Calculated for C13H20N [M+H]
+: 190.15903, Found: 
190.15902. 
 
N
H
12c  
N-(1-phenylethyl)benzenamine (12c). 12c was purified by flash silica gel chromatography 
(Hexane-EtOAc, v/v = 30:1) as colorless oil, yield: 99%. 1H NMR (600 MHz, CDCl3): ? 7.40-
7.39 (m, 2H), 7.36-7.33 (m, 2H), 7.26-7.24 (m, 1H), 7.13-7.10 (m, 2H), 6.69-6.66 (m, 1H), 6.55-
6.54 (m, 2H), 4.53-4.50 (m, 1H), 4.14 (br, 1H), 1.55 (d, J = 6.9 Hz, 3H). 13C NMR (150 MHz, 
CDCl3): ? 147.2, 145.1, 129.1, 128.6, 126.8, 125.8, 117.3, 113.4, 53.5, 24.9. HRMS Calculated 
for C14H16N [M+H]
+: 198.12773, Found: 198.12788. 
 
N
12d  
 
N-cyclohexyl-N-methylbenzenamine (12d). 12d was purified by flash silica gel 
chromatography (Hexane-EtOAc, v/v = 25:1) as colorless oil, yield: 99%. 1H NMR (600 MHz, 
CDCl3): ? 7.25-7.22 (m, 2H), 6.80-6.78 (m, 2H), 6.70-6.68 (m, 1H), 3.60-3.55 (m, 1H), 2.78 (s, 
3H), 1.86-1.79 (m, 4H), 1.71-1.68 (m, 1H), 1.55 (br, 1H), 1.50-1.43 (m, 2H), 1.41-1.33 (m, 2H), 
1.18-1.11 (m, 1H). 13C NMR (150 MHz, CDCl3): ? 150.0, 129.1, 116.2, 113.2, 58.2, 31.1, 30.0, 
26.2, 25.9. HRMS Calculated for C13H20N [M+H]
+: 190.15903, Found: 190.15902. 
 
N
H
12e  
N-benzyl-1-phenylethanamine (12e). 12e was purified by flash silica gel chromatography 
(Hexane-EtOAc, v/v = 8:1) as colorless oil, yield: 87%. 1H NMR (600 MHz, CDCl3): ? 7.40-
7.25 (m, 10H), 3.84 (q, J = 6.6 Hz, 1H), 3.79 (d, J = 13.2 Hz, 1H), 3.62 (d, J = 13.2 Hz, 1H), 
1.73 (br, 1H), 1.40 (d, J = 6.6 Hz, 3H). 13C NMR (150 MHz, CDCl3): ? 145.5, 140.6, 128.4, 
128.3, 128.1, 126.9, 126.8, 126.7, 57.5, 51.6, 24.4. HRMS Calculated for C15H18N [M+H]
+: 
212.14338, Found: 212.14339. 
 
N
H
O
12f  
N-(1-(furan-2-yl)ethyl)benzenamine (12f). 12f was purified by flash silica gel 
 55 
chromatography (Hexane-EtOAc, v/v = 25:1) as yellow oil, yield: 96%. 1H NMR (600 MHz, 
CDCl3): ? 7.31 (d, J = 1.2 Hz, 1H), 7.14 (m, 2H), 6.69 (t, J = 7.2 Hz, 1H), 6.61 (d, J = 7.8 Hz, 
2H), 6.27-6.26 (m, 1H), 6.14 (d, J = 3.0 Hz, 1H), 4.62 (q, J = 6.6 Hz, 1H), 3.84 (br, 1H), 1.53 (d, 
J = 6.6 Hz, 3H). 13C NMR (150 MHz, CDCl3): ? 157.2, 147.0, 141.4, 129.1, 117.7, 113.4, 
110.0, 105.0, 47.3, 20.8. HRMS Calculated for C12H14NO [M+H]
+: 188.10699, Found: 
188.10702. 
 
N
H
COOH
14a  
2-((naphthalene-3-yl)methylamino)-4-methylpentanoic acid (14a). 14a was purified by 
recrystalization as white solid, yield: 65%. 1H NMR (600 MHz, CD3OD): ? 8.33 (d, J = 8.4 Hz, 
1H), 7.97 (dd, J = 16.2 Hz; 8.4 Hz, 2H), 7.70-7.65 (m, 2H), 7.60-7.53 (m, 2H), 4.76 (d, J = 13.2 
Hz, 1H), 4.54 (d, J = 13.2 Hz, 1H), 3.66 (dd, J = 8.4 Hz; 6.0 Hz, 1H), 1.87-1.77 (m, 2H), 1.63-
1.58 (m, 1H), 1.00 (d, J = 6.6 Hz, 3H), 0.91 (d, J = 6.6 Hz, 3H). 13C NMR (150 MHz, CD3OD): 
? 135.4, 133.1, 131.4, 130.7, 129.9, 128.4, 127.5, 126.4, 124.4, 63.2, 41.2, 26.1, 23.2, 22.5. 
HRMS Calculated for C17H22NO2 [M+H]
+: 272.16451, Found: 272.16461. 
 
H
N
COOH
Cl
N
NH
14b  
(S)-2-(4-chlorobenzylamino)-3-(1H-imidazol-5-yl) propanoic acid (14b). 14b was purified 
by recrystalization as white solid, yield: 65%. 1H NMR (600 MHz, CD3OD): ? 7.69 (d, J = 1.2 
Hz, 1H), 7.48-7.46 (m, 2H), 7.44-7.42 (m, 2H), 6.98 (d, J = 1.2 Hz, 1H), 4.23 (d, J = 13.2 Hz, 
1H), 4.16 (d, J = 13.2 Hz, 1H), 3.73 (dd, J = 7.8 Hz; 4.8 Hz, 1H), 3.23 (dd, J = 15.6, 4.8 Hz, 
1H), 3.08 (dd, J = 15.6, 4.8 Hz, 1H). 13C NMR (150 MHz, CD3OD): ? 172.8, 136.4, 136.3, 
135.5, 132.6, 132.3, 130.2, 116.7, 63.6, 50.6, 49.6, 28.3. HRMS Calculated for C13H15ClN3O2 
[M+H]+: 280.08473, Found: 280.08487. 
 
S
H
N
COOH
Cl
14c  
2-(4-chlorobenzylamino)-4-(methylthio)butanoic acid (14c). 14c was purified by 
recrystalization as white solid, yield: 65%. 1H NMR (600 MHz, CDCl3 with CF3COOH): ? 7.43 
(d, J = 8.4 Hz, 2H), 7.34 (d, J = 8.4 Hz, 2H), 4.40 (d, J = 12.6, 1H), 4.32 (d, J = 12.6, 1H), 4.27 
(br, 1H), 2.70 (br, 2H), 2.36(br, 3H), 2.12 (br, 2H). 13C NMR (150 MHz, CDCl3 with 
CF3COOH): ? 137.6, 131.5, 130.3, 126.9, 59.2, 51.4, 30.0, 27.6, 15.1. HRMS Calculated for 
C12H17ClNO2S [M+H]
+: 274.06630, Found: 274.06636. 
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Cl
N
H
COOH
14d  
2-(4-chlorobenzylamino)acetic acid (14d). 14d was purified by recrystalization as white solid, 
yield: 55%. 1H NMR (600 MHz, CD3OD): ? 7.42-7.40 (m, 2H), 7.36-7.35 (m, 2H), 3.96 (s, 
2H), 3.29 (s, 2H). 13C NMR (150 MHz, CD3OD): ? 136.2, 135.2, 132.5, 129.9, 58.4, 54.9. 
HRMS Calculated for C9H11ClNO2 [M+H]
+: 200.04728, Found: 200.04723. 
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ORTEP Drawing of the Crystal Structures 
 
 
 
 
 
Figure 1. Perspective view of the molecular structure of 3K (C22H23NO2) with the atom labeling  
                scheme. The thermal ellipsoids are scaled to enclose 30% probability. CCDC number :  
                686861 
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Figure 2. Perspective view of the molecular structure of 3l (C16H23NO2) with the atom labeling   
                scheme.  Each cyclohexenyl ring suffers from a two-site conformational disorder.  For  
                purposes of clarity, only the major site is depicted.  The thermal ellipsoids are scaled to  
                enclose 30% probability. CCDC number:  687371 
 59 
 
Figure 3.   Perspective view of the molecular structures of the two independent molecules of 7a 
with their respective atom labeling schemes.  The thermal ellipsoids are scaled to 
enclose 30% probability. CCDC number: 741401. 
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